RYAN SPECIALTY HOLDINGS INC
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Consolidated Financial Statements
(Tabular amounts presented in thousands, except share and per share data)
- BASIS OF PRESENTATION
Nature of Operations
Ryan Specialty Holdings, Inc., (the “Company”) is a service provider of specialty products and solutions for insurance
brokers, agents, and carriers. These services encompass distribution, underwriting, product development, administration,
and risk management by acting as a wholesale broker and a managing underwriter or a program administrator with
delegated authority from insurance carriers. The Company’s offerings cover a wide variety of sectors including
commercial, industrial, institutional, governmental, and personal throughone operating segment, Ryan Specialty. With the
exception of the Company’s equity method investment, the Company does not take on any underwriting risk.
The Company is headquartered in Chicago, Illinois, and has operations inthe United States, the United Kingdom, Europe,
Canada, India, and Singapore. The Company’s Class A common stock is traded on the New York Stock Exchange under
the ticker symbol “RYAN”.
Organization
Ryan Specialty Holdings, Inc., was formed as a Delaware corporation on March 5, 2021, for the purpose of completing an
IPO and to carry on the business of the LLC. New Ryan Specialty, LLC, or New LLC, was formed as a Delaware limited
liability company on April 20, 2021, for the purpose of becoming, subsequent to our IPO, an intermediate holding
company between Ryan Specialty Holdings, Inc., and the LLC. The Company is the sole managing member of New LLC.
New LLC is a holding company with its sole material asset being a controlling equity interest in the LLC. The Company
operates and controls the business and affairs of the LLC through New LLC and, through the LLC, conducts its business.
Accordingly, the Company consolidates the financial results of New LLC, and therefore the LLC, and reports the non-
controlling interests of New LLC’s Common Units on its consolidated financial statements. As the LLC is substantively
the same as New LLC, for the purpose of this document, we will refer to both New LLC and the LLC as the “LLC”. As of
December 31, 2024, the Company owned 47.9% of the outstanding LLC Common Units.
Basis of Presentation
The accompanying consolidated financial statements and notes thereto have been prepared in accordance with U.S. GAAP.
The consolidated financial statements include the Company’s accounts and those of all controlled subsidiaries. In the
opinion of management, the consolidated financial statements include all normal recurring adjustments necessary to present
fairly the Company’s consolidated financial position, results of operations, and cash flows for all periods presented. Certain
prior period amounts in the Consolidated Statements of Cash Flows have been reclassified toconform to the current year
presentation.
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and its subsidiaries that it controls due to
ownership of a majority voting interest or pursuant to variable interest entity (“VIE”) accounting. All intercompany
transactions and balances have been eliminated in consolidation.
The Company, through its intermediate holding company, New LLC, owns a minority economic interest in, and operates
and controls the businesses and affairs of, the LLC. The LLC is a VIE of the Company and the Company is the primary
beneficiary of the LLC as the Company has both the power to direct the activities that most significantly impact the LLC’s
economic performance and has the obligation to absorb losses of, and receive benefits from, the LLC, which could be
significant to the Company. Accordingly, the Company has prepared these consolidated financial statements in accordance
with Accounting Standards Codification (“ASC”) 810, Consolidation (“ASC 810”). ASC 810 requires that if an entity is
the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE should be included in the
consolidated financial statements of such entity. The Company’s relationship with the LLC results in no recourse to the
general credit of the Company and the Company has no contractual requirement to provide financial support to the LLC.
The Company shares in the income and losses of the LLC indirect proportion to the Company’s ownership percentage.
Use of Estimates
The preparation of the consolidated financial statements and notes thereto requires management to make estimates,
judgments, and assumptions that affect the amounts reported in the consolidated financial statements and in the notes
thereto. Such estimates and assumptions could change in the future as circumstances change or more information becomes
available, which could affect the amounts reported and disclosed herein.
- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Segment Reporting
In accordance with ASC 280, Segment Reporting, Ryan Specialty’s operations are reported as a single operating and
reporting segment. See Note 20, Segment Reporting, for additional information on the Company’s segment reporting.
Revenue Recognition
The Company generates revenues primarily through commissions and fees from customers, as well as compensation from
insurance and reinsurance companies for services provided to them.
The Company incurs both costs to fulfill contracts, principally in pre-placement activities, and costs to obtain contracts,
principally through certain sales commissions paid to employees. For situations in which the renewal period is one year or
less and renewal costs are commensurate with the initial contract, the Company applies a practical expedient and
recognizes the costs of obtaining a contract as an expense when incurred.
Net Commissions and Policy Fees
Net commissions and policy fees revenue is primarily based on a percentage of premiums or fees received for an agreed-
upon level of service. The Company’s customers for this revenue stream are agents of the insured. The net commissions
and policy fees are recognized at the point in time when an insurance policy is bound and issued, which occurs on the later
of the policy effective date or the date the Company receives a request to bind coverage from the customer. Most insurance
premiums are subject to cancellations; therefore, commission revenue is considered to be variable consideration at the
contract effective date and is recognized net of a constraint for estimated policy cancellations. Estimated policy
cancellations are based upon the Company’s historical cancellations. Any endorsement made to a contract is treated as a
new contract with revenue recognized on the later of the endorsement effective date or the date the Company receives a
request to bind coverage from the customer.
Supplemental and Contingent Commissions
Supplemental and contingent commissions are additional revenues paid to the Company based on the volume and/or
underwriting profitability of the eligible insurance contracts placed. The Company’s performance obligation is satisfied and
revenue is recognized over time using the output method as the Company places eligible or profitable policies. For this
revenue stream, the customer is the carrier as the carrier is the entity that will ultimately pay the Company additional
revenues once certain volume and profitability targets are achieved by the carrier. Because of the limited visibility into the
satisfaction of performance indicators outlined in the contracts, the Company constrains such revenues until the time that
the carrier provides explicit confirmation ofamounts owed to the Company to avoid a significant reversal of revenue in a
future period. The uncertainty regarding the ultimate transaction price for contingent commissions is principally the
profitability of the underlying insurance policies placed as determined by the development of loss ratios maintained by the
carriers. The uncertainty is resolved over the contractual term as actual results are achieved.
Loss Mitigation Fees
Loss mitigation fees, or mergers and acquisitions (“M&A”) fees, consist of revenue earned from the review of due
diligence and other relevant information in underwriting a risk. The customer of this revenue stream is the agent of the
insured. The performance obligation is the production of an Expense Agreement (“EA”) or Letter of Intent (“LOI”). As the
M&A fees are not dependent on the outcome of the risk being insured, the Company recognizes these fees at the point in
time when control transfers to the customer, which occurs on the effective date of an executed EA or LOI.
Disaggregation of Revenue
Wholesale Brokerage revenue primarily includes insurance commissions and fees for services rendered to retail agents and
brokers, as well as supplemental and contingent commissions from carriers. Wholesale Brokerage distributes a wide range
and diversified mix of specialty property, casualty, professional lines, and workers’ compensation insurance products from
insurance carriers to retail brokerage firms.
Binding Authority revenue primarily includes insurance commissions for services rendered, as well as supplemental and
contingent commissions from carriers. The Company’s binding authorities receive underwriting authority from a variety of
carriers for both Admitted and non-admitted business for small to mid-size risks. Wholesale binding authorities generally
have authority to bind coverage on behalf of an insurance carrier for a specific type of risk, subject to agreed-upon
guidelines and limits. Wholesale binding authorities receive submissions for insurance directly from retail brokers, evaluate
price, make underwriting decisions regarding these submissions, and bind and issue policies on behalf of insurance carriers.
Wholesale binding authorities are typically created to handle large volumes of small-premium policies across commercial
and personal lines within strictly defined underwriting criteria. Binding authorities allow the insured to access additional
capital, and the carrier to efficiently aggregate its distribution.
Underwriting Management revenue primarily includes insurance commissions for services rendered, including contingent
commissions for placing profitable business with carrier partners, as well as loss mitigation fees. Underwriting
Management provides retail and wholesale brokers specialty market expertise in distinct and complex market niches
underserved in today’s marketplace through MGUs, which act on behalf of insurance carriers that have given the Company
the authority to underwrite and bind coverage for specific risks in a cost-effective manner, and programs that offer
commercial and personal insurance for specific product lines or industry classes.
Contract Balances
Contract assets, which arise primarily from the Company’s supplemental and contingent commission arrangements and
medical stop loss business, are included within Commissions and fees receivable – net on the Consolidated Balance Sheets.
These assets relate to the unbilled amounts of services for which the Company recognizes revenue over time. Payment
related to contract assets is typically due within one year of the completed performance obligation. Occasionally, the
Company receives cash payments from customers in advance of the Company’s performance obligation being satisfied,
which represent a contract liability. Contract liabilities are recognized as revenue when the performance obligations are
satisfied.
Cash and Cash Equivalents
Cash and cash equivalents include cash in demand deposit accounts and short-term investments, consisting principally of
AAA-rated money market funds and treasury bills, having original maturities of 90 days or less. Interest income is
recognized in Interest expense, net on the Consolidated Statements of Income.
Commissions and Fees Receivable
The Company earns commissions and fees through its Wholesale Brokerage, Binding Authority and Underwriting
Management Specialties. The Company records a receivable once a performance obligation is satisfied. In some instances,
the Company advances premiums on behalf of clients, or advances claims payments and refunds to clients on behalf of
underwriters. These amounts are reflected within Commissions and fees receivable – net on the Consolidated Balance
Sheets.
The Company’s receivables are shown net of an allowance for credit losses, which is estimated based on a combination of
factors, including evaluation of historical write-offs, current economic conditions, aging of balances, and other qualitative
and quantitative analyses.
Fiduciary Assets, Fiduciary Liabilities, and Related Income
In its role as an insurance intermediary, the Company collects and remits amounts between insurance agents and brokers
and insurance underwriters. Because these amounts are collected on behalf of third parties, they are excluded from the
measurement of the transaction price. Similarly, the Company elected to exclude surplus lines taxes from the measurement
of the transaction price, as these are assessed by and remitted to governmental authorities. The Company recognizes
fiduciary amounts collectible and held on behalf of others, including insurance policyholders, clients, other insurance
intermediaries, and insurance carriers, as Fiduciary cash and receivables on the Consolidated Balance Sheets. Cash and
cash equivalents held in excess of the amount required to meet the Company’s fiduciary obligations are recognized as Cash
and cash equivalents on the Consolidated Balance Sheets. The Company recognizes premiums, claims payable, and surplus
lines taxes as Fiduciary liabilities on the Consolidated Balance Sheets. The Company does not have any rights or
obligations in connection with these amounts with the exception of segregating these amounts from the Company’s
operating accounts and liabilities.
Unremitted insurance premiums are held in a fiduciary capacity until disbursement. The Company holds these funds in
cash and, where permitted, cash equivalents, including AAA-rated money market funds registered with the U.S. Securities
and Exchange Commission under Rule 2a-7 of the Investment Company Act of 1940. Interest income is earned on the
unremitted funds, which is included in Fiduciary investment income in the Consolidated Statements of Income. Interest
earned on fiduciary funds held is not accounted for under ASC 606, Revenue from Contracts with Customers.
Goodwill and Intangible Assets
Goodwill
Goodwill represents the excess of consideration transferred over the fair value of the net assets acquired in the acquisition
of a business. The Company recognizes goodwill as the amount of consideration transferred which cannot be assigned to
other tangible or intangible assets and liabilities.
The Company reviews goodwill for impairment at least annually, and whenever events or changes in circumstances
indicate that the carrying value of the reporting unit may not be recoverable. In the performance of the annual evaluation,
the Company also considers qualitative and quantitative developments between the date of the goodwill impairment review
and the fiscal year end to determine if an impairment should be recognized.
The Company reviews goodwill for impairment at the reporting unit level, which coincides with the operating segment,
Ryan Specialty. The determinations of impairment indicators and the fair value of the reporting unit are based on estimates
and assumptions related to the amount and timing of future cash flows and future interest rates. Such estimates and
assumptions could change in the future as more information becomes available, which could impact the amounts reported
and disclosed herein.
Intangible Assets
Intangible assets consist primarily of customer relationships. Customer relationships are amortized over their estimated
useful lives, ranging fromone tofifteen years, in proportion with the realization of their economic benefit. Generally, the
Company uses outside valuation specialists to value acquired intangible assets. Other intangible assets include trade names
and internally developed software, which are amortized over their estimated lives, typicallyone tothree years and between
four toseven years, respect ively. The Company hasno indefinite-lived intangible assets.
Equity Method Investment
The Company uses the equity method to account for its investment in a related party for which the Company has the ability
to exercise significant influence, but not control, over the investee’s operating and financial policies. The equity method
investment in related party is recorded at cost and adjusted to recognize the Company’s proportionate share of the
investee’s net income or loss. The Company’s proportionate share of the other comprehensive income or loss from equity
method investments is reflected on the Consolidated Statements of Comprehensive Income. The Company’s equity method
investment in a related party is evaluated for impairment whenever events or changes in circumstances indicate that the
carrying value of the assets may not be recoverable. If the impairment is determined to be other-than-temporary, the
Company will recognize an impairment loss equal to the difference between the expected realizable value and the carrying
value of the investment.
Leases
The Company evaluates contracts entered into to determine whether the contract involves the use of an asset. The
Company then evaluates whether it controls the use of the asset, which is determined by assessing whether it obtains
substantially all economic benefits from the use of the asset, and whether it has the right to direct the use of the asset. If
these criteria are met and a lease has been identified, the Company accounts for the contract under the requirements of ASC
842, Leases.
The Company’s leased assets consist primarily of real estate for occupied offices and office equipment. Certain of these
leases have options permitting renewals for additional periods or clauses allowing for early termination, and where those
are reasonably certain to be executed, they are recognized as a component of the initial lease term. All of the Company’s
real estate leases and office equipment leases are recognized as operating leases. The Company also subleases some real
estate properties to third parties, which are classified as operating leases. The Company recognizes lease payments for
short-term leases of twelve months or less on a straight-line basis over the lease term in the Consolidated Statements of
Income.
For leases in which an implicit rate is not provided in the contract, the Company uses an incremental borrowing rate based
on the information available at the lease commencement date in determining the present value of lease payments. The
Company does not account for separate lease components of a contract and its associated non-lease components as a single
lease component. Further, variable expenses related to real estate and equipment leases are expensed as incurred.
At the lease commencement for operating leases, the Company recognizes the total lease liability through the lease term as
the present value of all remaining payments, discounted by the rate determined at commencement on the Consolidated
Balance Sheets. Operating leases are included in Lease right-of-use assets, Current Operating lease liabilities, and Non-
current Operating lease liabilities on the Consolidated Balance Sheets. In the event the lease liability is remeasured due to a
change in the scope of, or the consideration for, a lease, an adjustment is made to the right-of-use asset. If a right-of-use
asset is impaired, the impairment charge is recognized within General and administrative expense in the Consolidated
Statements of Income.
Equity-Based Compensation
The Company issues equity-based awards to employees in the form of Restricted Stock, Restricted Stock Units (“RSUs”),
Performance Stock Units (“PSUs”), Stock Options, Restricted Common Units, Restricted LLC Units (“RLUs”),
Performance LLC Units (“PLUs”), and Class C Incentive Units. Compensation expense for equity awards is measured at
the grant date fair value. The grant date fair value of Restricted Stock and RSUs is based on the closing price of the
underlying stock the day prior to issuance. The grant date fair value of RLUs is valued consistently to RSUs less a discount
for the lower distributions that they are entitled to accrue. The grant date fair value of Stock Options is estimated using the
Black-Scholes option pricing model, and the grant date fair value of PSUs, PLUs, Restricted Common Units and Class C
Incentive Units is estimated using a Monte Carlo simulation based pricing model. These pricing models require
management to make assumptions with respect to the fair value of the equity awards on the grant date, including the
expected term of the award, the expected volatility of the Company’s stock based on a period of time generally
commensurate with the expected term of the award, risk-free interest rates, and expected dividend yields of the Company’s
Class A common stock, among other items including the Company’s Class A common stock price and taxable income
forecasts. These assumptions reflect the Company’s best estimates, but they involve inherent uncertainties based on market
conditions generally outside the control of the Company. As a result, if other assumptions are used, compensation expense
could be materially impacted.
The Company accounts for equity-based compensation in accordance with ASC 718, Compensation- Stock Compensation
(“ASC 718”). In accordance with ASC 718, compensation expense is measured at estimated fair value of the equity-based
awards and is expensed over the vesting period during which an employee provides service in exchange for the award.
Compensation expense is recognized using the graded vesting attribution method and forfeitures are accounted for as they
occur. Equity-based compensation expense is recorded in Compensation and benefits on the Consolidated Statements of
Income. See Note 11, Equity-Based Compensation, for additional information on the Company’s equity-based
compensation awards.
Earnings Per Share
Basic earnings per share is computed by dividing net earnings attributable to Ryan Specialty Holdings, Inc., by the number
of weighted average shares of Class A common stock outstanding during the period. Diluted earnings per share is
computed by dividing net earnings attributable to Ryan Specialty Holdings, Inc., by the number of weighted-average shares
of Class A common stock outstanding during the period after adjusting for the impact of securities that would have a
dilutive effect on earnings per share. See Note 12, Earnings Per Share, for additional information on dilutive securities.
Derivative Instruments and Hedging Activities
The Company uses derivative financial instruments to manage the risk profile of existing underlying exposures, including
changes in interest rates and foreign currency exchange rates. For cash flow hedges, the Company assesses the
effectiveness both at inception and on an on-going basis. For hedging derivatives that qualify as effective cash flow hedges,
the Company records the cumulative changes in the fair value of the financial instrument in Other comprehensive income
(loss). Amounts recorded in Other comprehensive income (loss) are reclassified into earnings in the periods in which
earnings are affected by the hedged cash flow. If a derivative is not designated as an accounting hedge, such as forward
contracts periodically used by the Company to limit foreign currency exchange rate exposure, the change in fair value is
recorded in earnings. The Company utilizes an interest rate cap for interest rate risk management purposes. The Company
amortizes the premium paid for the interest rate cap on a straight-line basis over the life of the instrument. The premium
amortization is recognized in Interest expense, net on the Consolidated Statements of Income. The Company recognizes
cash flows related to designated and non-designated hedges in the same section of the Consolidated Statement of Cash
Flows as the cash flows related to the item being hedged. The Company does not hold or issue derivative instruments for
trading or speculative purposes. See Note 13, Derivatives, for further discussion of derivative financial instruments.
Defined Contribution Plan
The Company offers a defined contribution retirement benefit plan, the Ryan Specialty Employee Savings Plan (the
“Savings Plan”), to all eligible U.S. employees, based on a minimum number of service hours in a year. Under the Savings
Plan, eligible employees may contribute a percentage of their compensation, subject to certain limitations. Further, the
Savings Plan authorizes the Company to make a discretionary matching contribution, which has historically equaled 50%
of each eligible employee’s contribution. The Company makes discretionary matching contributions throughout the year
and recognizes expense for the matching contribution in the period where requisite employee service is performed. The
Company recognized expense related to discretionary matching contributions of$25.3 million,$21.3 million, and$17.4
million for the years ended December 31, 2024,2023, and 2022, respectively, which was included in Compensation and
benefits on the Consolidated Statements of Income.
Deferred Compensation Plan
The Company offers a non-qualified deferred compensation plan to certain senior employees and members of management.
Under this plan, amounts deferred remain assets of the Company and are subject to the claims of the Company’s creditors
in the event of insolvency. Amounts deferred are not invested in any funds. However, the liability balance is updated to
reflect hypothetical interest, earnings, appreciation, losses, and depreciation that would be accrued or realized if the
deferred compensation amounts had been invested in the applicable benchmark investments. Changes in the value of
deferred amounts held are recognized within Compensation and benefits in the Consolidated Statements of Income. The
Company recognized liabilities for employee deferrals, inclusive of changes in the value of deferred amounts held, of$5.2
million and$3.5 million in Current Accrued compensation as of December 31, 2024 and 2023, respectively, and$36.5
million and$22.4 million in Non-current Accrued compensation on the Consolidated Balance Sheets as of December 31,
2024 and 2023, respectively.
Non-Controlling Interests
As noted above, the Company consolidates the financial results of the LLC; therefore, it reports non-controlling interests
based on the LLC Common Units not owned by the Company on the Consolidated Balance Sheets. Net income and other
comprehensive income (loss) are attributed to the non-controlling interests based on the weighted average LLC Common
Units outstanding during the period and are presented on the Consolidated Statements of Income and Comprehensive
Income. Refer to Note 10, Stockholders’ Equity, for more information.
The non-controlling interest holders may, subject to certain exceptions, exchange some or all of their LLC Common Units
for newly-issued shares of Class A common stock on aone-for-onebasis, or for cash, at the Company’s election
(determined by a majority of the Company’s directors who are disinterested) and only to the extent that the Company has
received cash proceeds pursuant to a secondary offering. As any redemption settled in cash would be limited to proceeds
received from the sale of new permanent equity securities, the Non-controlling interests are classified as permanent equity
on the Consolidated Balance Sheets.
Captive Insurance Cells
Through acquisitions, the Company has an ownership interest inthree entities that hold segregated account protected cell
captives. These entities are structured with protected cell captives for each insured (“Captive Cells”) and the core regulated
companies (“Core Companies”). The Core Companies are owned and operated by the Company, and are not exposed to the
insurance and investment risks that the Captive Cells are designed to create and distribute on behalf of the insureds. The
Company has a variable interest in the Core Companies due to its ownership interest, however, as the Core Companies are
not exposed to the variability of the Captive Cells, only the activity of the regulated Core Companies is recorded in the
Company’s consolidated financial statements, including cash and any expenses incurred to operate the Captive Cells.
Litigation and Contingent Liabilities
The Company is subject to various legal actions related to claims, lawsuits, and proceedings incident to the nature of the
business. The Company records liabilities for loss contingencies when it is probable that a liability has been incurred on or
before the balance sheet date and the amount of the liability can be reasonably estimated. The Company does not discount
such contingent liabilities and recognizes related legal costs, such as fees and expenses of external counsel and other
service providers, as period expenses when incurred. Loss contingencies are recorded within Accounts payable and accrued
liabilities on the Consolidated Balance Sheets. Significant management judgment is required to estimate the amounts of
such contingent liabilities. The Company records loss recoveries from E&O insurance coverage, up to the amount of the
financial statement loss incurred, when the realization of the indemnity for a claim presented under the Company’s E&O
insurance coverage is deemed probable in Other current assets on the Consolidated Balance Sheets. In order to assess
potential liabilities and any recoveries, the Company analyzes the litigation exposure based upon available information,
including consultation with counsel handling the defense of these matters. As these liabilities are uncertain by their nature,
the recorded amounts may change due to a variety of factors, including new developments or changes in the approach, such
as changing the settlement strategy as applicable to a matter.
Foreign Currency Translation
The Company assigns functional currencies to its foreign operations, which are generally the currencies of the local
operating environment. Balances denominated in non-functional currency are remeasured to the functional currency using
current exchange rates, and the resulting foreign exchange gains or losses are reflected in earnings. Functional currency
balances are then translated into the reporting currency (i.e., USD) using (i) exchange rates at the balance sheet date for
items reported as assets or liabilities on the Consolidated Balance Sheets, (ii) historical rates for items reported in the
Consolidated Statements of Stockholders’ Equity other than retained earnings, and (iii) average exchange rates for items
recorded in earnings and included in retained earnings. The resulting change in unrealized translation gains or losses is a
component of Accumulated other comprehensive income within the Consolidated Balance Sheets.
Income Taxes
The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are
recognized for the future tax consequences attributable to differences between the financial statement carrying values of
existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted
tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect of a
change in tax rates on deferred tax assets and deferred tax liabilities is recognized in income in the period that includes the
enactment date.
The Company recognizes deferred tax assets to the extent that it is believed that these assets are more likely than not to be
realized. In making such a determination, the Company considers all available positive and negative evidence, including
future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies,
carryback potential if permitted under the tax law, and results of recent operations. A valuation allowance is provided if it
is determined that it is more likely than not that the deferred tax asset will not be realized.
The Company evaluates and accounts for uncertain tax positions inaccordance with ASC 740, Income Taxes, using a two-
step approach. Recognition (step one) occurs when the Company concludes that a tax position, based solely on its technical
merits, is more likely than not to be sustainable upon examination. Measurement (step two) determines the amount of tax
benefit that is greater than 50% likely to be realized upon ultimate settlement with a taxing authority that has full
knowledge of all relevant information. Derecognition of a tax position that was previously recognized would occur if the
Company subsequently determines that a tax position no longer meets the more likely than not threshold of being
sustained. The Company records interest, and penalties where applicable, net of any applicable related income tax benefit,
on potential income tax contingencies as a component of Income tax expense in the Consolidated Statements of Income.
Holders of the LLC Common Units, including the Company, incur U.S. federal, state, and local income taxes on their share
of any taxable income of the LLC. The LLC Operating Agreement provides for pro rata cash distributions (“Members’ Tax
Distributions”) to the holders of the LLC Common Units in an amount generally calculated to provide each holder of LLC
Common Units with sufficient cash to cover their tax liability in respect of the LLC Common Units. In general, these
Members’ Tax Distributions are computed based on the LLC’s estimated taxable income, multiplied by an assumed tax rate
as set forth in the LLC Operating Agreement.
Tax Receivable Agreement (TRA)
The Company is party to a TRA with current and certain former LLC Unitholders. The TRA provides for the payment by
the Company to the current and certain former LLC Unitholders of 85% of the amount of net cash savings, if any, in U.S.
federal, state, and local income taxes the Company actually realizes (or under certain circumstances are deemed to realize)
from (i) certain increases in the tax basis of the assets of the LLC resulting from purchases or exchanges of LLC Common
Units (“Exchange Tax Attributes”), (ii) certain tax attributes of the LLC that existed prior to the IPO (“Pre-IPO M&A Tax
Attributes”), (iii) certain favorable “remedial” partnership tax allocations to which the Company becomes entitled (if any),
and (iv) certain other tax benefits related to the Company entering into the TRA, including tax benefits attributable to
payments that the Company makes under the TRA (“TRA Payment Tax Attributes”).
The Company accounts for amounts payable under the TRA in accordance with ASC 450, Contingencies. The amounts
payable under the TRA will vary depending upon a number of factors, including the timing of exchanges by the LLC
Unitholders, the amount of gain recognized by the LLC Unitholders, the amount and timing of the taxable income the
Company generates in the future, and the federal tax rates then applicable. Actual tax benefits realized by the Company
may differ from tax benefits calculated under the TRA as a result of the use of certain assumptions in the agreement. Any
such changes in these factors or changes in the Company’s determination of the need for a valuation allowance related to
the tax benefits acquired under the TRA could adjust the Tax Receivable Agreement liabilities recognized on the
The Company accounts for the effects of the increases in tax basis and associated liabilities under the TRA arising from
exchanges with respect to Exchange Tax Attributes and TRA Payment Attributes (i) by recording an increase in deferred
tax assets for the estimated income tax effects of the increases in tax basis based on the enacted federal and state tax rates at
the date of the exchange, (ii) to the extent it is estimated that the Company will not realize the full benefit represented by
the deferred tax asset, based on an analysis that will consider, among other things, our expectation of future earnings, by
reducing the deferred tax asset with a valuation allowance, and (iii) by recording an offsetting increase in the Tax
Receivable Agreement liability for 85% of the realizable tax benefit and an increase in Additional paid-in capital for the
remaining 15% of the realizable tax benefit on the Consolidated Balance Sheets.
The Company accounts for the associated liability under the TRA arising from exchanges with respect to the Pre-IPO
M&A Tax Attributes by recording an increase in the Tax Receivable Agreement liability for 85% of the realizable tax
benefits associated with the Pre-IPO M&A Tax Attributes with an offsetting decrease to Additional paid-in capital on the
Subsequent changes to the initial establishment of the increases in deferred tax assets and Tax Receivable Agreement
liability between reporting periods will be recognized in the Consolidated Statements of Stockholders’ Equity as the
exchanges represent transactions among shareholders. Subsequent changesin the fair value of the Tax Receivable
Agreement liabilities between reporting periods, as well as any interest accrued on the TRA between the Company’s annual
tax filing date and the TRA payment date, are recognized in the Consolidated Statements of Income. In the unlikely event
of an early termination of the TRA, either due to Company default or a change of control, the Company is required to pay
to each holder of the TRA an early termination payment equal to the discounted present value of all unpaid TRA payments.
Recently Issued Accounting Pronouncements
New Accounting Pronouncements Recently Adopted
In November 2023, the FASB issued ASU 2023-07 Segment Reporting (Topic 280) — Improvements to Reportable
Segment Disclosures, which requires disclosure of incremental segment information on an annual and interim basis. This
ASU is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning
after December 15, 2024, with early adoption permitted. The amendments in this ASU should be applied retrospectively to
all prior periods presented in the financial statements. The Company adopted this standard retrospectively as of December
31, 2024, resulting in incremental disclosures on segment information. See Note 20, Segment Reporting, for additional
information on the Company’s segment reporting.
In March 2024, the FASB issued ASU 2024-01 Compensation — Stock Compensation (Topic 718) — Scope Application of
Profits Interest and Similar Awards, which provides illustrative examples to demonstrate how an entity should apply the
scope guidance in paragraph 718-10-15-3 to determine whether profits interests and similar awards should be accounted for
in accordance with Topic 718. This ASU is effective for public companies for fiscal years beginning after December 15,
2024, but early adoption is permitted. The Company adopted this standard retrospectively on January 1, 2024, with no
material impact to the consolidated financial statements or disclosures.
In March 2024, the FASB issued ASU 2024-02 Codification Improvements — Amendments to Remove References to the
Concept Statements, which removes references to various FASB Concepts Statements in order to simplify the Codification
and draw a distinction between authoritative and nonauthoritative literature. This ASU is effective for public companies for
fiscal years beginning after December 15, 2024, but early adoption is permitted. The Company adopted this standard
prospectively on January 1, 2024, with no material impact to the consolidated financial statements or disclosures.
Recently Issued Accounting Pronouncements Not Yet Adopted
In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740) — Improvements to Income Tax Disclosures,
which includes amendments that further enhance income tax disclosures, primarily through standardization and
disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This ASU is effective for annual
periods beginning after December 15, 2024, with early adoption permitted. The amendments in this ASU should be applied
on a prospective basis, however, retrospective application is permitted. The Company is currently evaluating the impact of
adopting this ASU on its income tax disclosures.
In November 2024, the FASB issued ASU 2024-03 Income Statement — Reporting Comprehensive Income — Expense
Disaggregation Disclosures (Subtopic 220-40) — Disaggregation of Income Statement Expenses, which requires the
disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial
statements. This ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal
years beginning after December 15, 2027, but early adoption is permitted. The amendments in this ASU may be applied
either prospectively or retrospectively. The Company is currently evaluating the impact of adopting this ASU on its
disclosures.
- REVENUE FROM CONTRACTS WITH CUSTOMERS
Disaggregation of Revenue
The following table summarizes revenue from contracts with customers by Specialty:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Wholesale Brokerage | $1,489,077 | $1,319,056 | $1,129,241 |
| Binding Authority | 320,379 | 275,961 | 231,048 |
| Underwriting Management | 646,215 | 431,579 | 351,572 |
| Total Net commissions and fees | $2,455,671 | $2,026,596 | $1,711,861 |
Contract Balances
The contract assets balance, which is included within Commissions and fees receivable –net on the Consolidated Balance
Sheets, was$35.6 million and$13.4 million as of December 31, 2024 and 2023, respectively. The contract liability balance
related to deferred revenue, which is included in Accounts payable and accrued liabilities on the Consolidated Balance
Sheets, was$8.7 million and$7.8 million as of December 31, 2024 and 2023, respectively. During the year ended
December 31, 2024,$7.5 million of the contract liabilities outstanding as of December 31, 2023, were recognized in
revenue.
- MERGERS AND ACQUISITIONS
2024 Acquisitions
On May 1, 2024, the Company completed the acquisition of Castel Underwriting Agencies Limited (“Castel”), a managing
general underwriting platform headquartered in London, England, for cash consideration of$247.6 million,$2.2 million of
RYAN Class A common stock, and contingently returnable consideration of$4.9 million. During the year ended
December 31, 2024, measurement period adjustments related to deferred tax liabilities of$1.6 million, taxes payable of
$0.9 million, and working capital of$0.5 million were recognizedas a net $2.0 million decrease in Goodwill on the
On August 30, 2024, the Company completed the acquisition of US Assure Insurance Services of Florida, Inc. (“US
Assure”), a program specializing in builder’s risk insurance headquartered in Jacksonville, Florida, for cash consideration
of$1,079.8 million and contingent consideration of$103.8 million. During the year ended December 31, 2024, a
measurement period adjustment related to working capitalof $5.2 million was recognized as an increase in Goodwill on the
On September 1, 2024, the Company completed the acquisition of certain assets of Greenhill Underwriting Insurance
Services, LLC (“Greenhill”), an MGU focused on the allied health industry headquartered in Houston, Texas, for cash
consideration of$11.7 million. During the year ended December 31, 2024, measurement period adjustments related to
working capital of$0.4 million and the initial valuation of customer relationships of$0.1 million were recognized as a net
$0.3 million increase in Goodwill on the Consolidated Balance Sheets.
On September 13, 2024, the Company completed the acquisition of the Property and Casualty (“P&C”) MGUs owned by
Ethos Specialty Insurance, LLC (“Ethos P&C”) for cash consideration of$44.0 million. Ethos P&Cis composed ofeight
programs which underwrite on behalf of insurance carriers.
On October 1, 2024, the Company completed the acquisition of certain assets of EverSports & Entertainment Insurance,
Inc. (“EverSports”), an MGU focused on sports, leisure, and entertainment headquartered in Carmel, Indiana, for$43.1
million of cash consideration. Total consideration for this acquisition also includes contingent consideration, however, the
contingent consideration value was de minimis as of the acquisition date.
On November 4, 2024, the Company completed the acquisition of Innovisk Capital Partners (“Innovisk”), which is
composed ofseven specialty MGUs headquartered in London, England, for cash consideration of$426.8 million.
The$103.8 million of contingent consideration liabilities and$4.9 million of contingently returnable consideration
established for the acquisitions that occurred during the year ended December 31, 2024, were measured at the estimated
acquisition date fair value and were non-cash investing transactions. These arrangements are based on the individual
businesses’ revenue or EBITDA targets, or both, over the next two to three fiscal years.
The following table summarizes the estimated fair values of the aggregate assets and liabilities acquired during the year
ended December 31, 2024, as of the date of each acquisition and includes any measurement period adjustments:
| Castel | US Assure | Greenhill | Ethos P&C | EverSports | Innovisk | Total | |
|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $10,294 | $7,181 | $314 | $— | $— | $18,046 | $35,835 |
| Commissions and fees receivable – net | 10,657 | 50,111 | 46 | — | 1,788 | 11,520 | 74,122 |
| Fiduciary cash and receivables | 119,333 | 122,136 | 3,222 | — | 19,840 | 29,643 | 294,174 |
| Goodwill | 188,611 | 463,090 | 7,570 | 24,246 | 24,417 | 295,234 | 1,003,168 |
| Customer relationships1 | 97,695 | 670,300 | 4,285 | 21,100 | 17,400 | 155,800 | 966,580 |
| Other intangible assets | 875 | 9,900 | — | — | — | 11,200 | 21,975 |
| Lease right-of-use assets | 1,269 | 2,256 | — | — | — | 551 | 4,076 |
| Other current and non-current assets | 1,312 | 606 | — | — | — | 1,640 | 3,558 |
| Total assets acquired | $430,046 | $1,325,580 | $15,437 | $45,346 | $63,445 | $523,634 | $2,403,488 |
| Accounts payable and accrued liabilities | 254 | 9,284 | — | — | — | 3,609 | 13,147 |
| Accrued compensation | 43,688 | 3,138 | 49 | 1,371 | 538 | 27,719 | 76,503 |
| Fiduciary liabilities | 119,433 | 122,136 | 3,222 | — | 19,840 | 29,643 | 294,274 |
| Operating lease liabilities | 1,269 | 2,256 | — | — | — | 551 | 4,076 |
| Deferred tax liabilities | 20,173 | — | — | — | — | 35,268 | 55,441 |
| Total liabilities assumed | $184,817 | $136,814 | $3,271 | $1,371 | $20,378 | $96,790 | $443,441 |
| Net assets acquired | $245,229 | $1,188,766 | $12,166 | $43,975 | $43,067 | $426,844 | $1,960,047 |
1 The customer relationships acquired during the year ended December 31, 2024, have a weighted average amortization
period of 13.4 years.
Estimates and assumptions used in the acquisition valuations are subject to change within the measurement period up to
one year from each acquisition date. Estimated tax deductible goodwill of$735.8 million was generated as a result of these
acquisitions. The Company recognized acquisition-related expenses, which include advisory, legal, accounting, valuation,
and other costs related to diligence, for the acquisitions above of$19.1 million during the year ended December 31, 2024,
in General and administrative expense on the Consolidated Statements of Income. In conjunction with the closing of the
Castel acquisition, the deal-contingent foreign currency forward (the “Deal-Contingent Forward”), as described in Note 13,
Derivatives, was settled.
The Company recognized an aggregate$102.8 million of revenue related to the 2024 acquisitions above from their
respective acquisition dates during the year ended December 31, 2024.
2023 Acquisitions
On January 3, 2023, the Company completed the acquisition of certain assets of Griffin Underwriting Services (“Griffin”),
a binding authority specialist and wholesale insurance broker headquartered in Bellevue, Washington, for cash
consideration of$115.5 million.
On July 1, 2023, the Company completed the acquisitions of certain assets of ACE Benefit Partners, Inc. (“ACE”), a
medical stop loss general agent headquartered in Eagle, Idaho, and Point6 Healthcare, LLC (“Point6”), a distributor of
medical stop loss insurance on behalf of retail brokers and third-party administrators headquartered in Plano, Texas, for an
aggregate$46.8 million of cash consideration and$2.3 million of contingent consideration. During the year ended
December 31, 2024, a measurement period adjustment related to the initial valuation of contingent consideration of$0.6
million was recognized as an increase in Goodwill on the Consolidated Balance Sheets.
On July 3, 2023, the Company completed the acquisition of Socius Insurance Services (“Socius”), a national wholesale
insurance broker headquartered in Northern California, for$253.5 million of cash consideration,$5.8 million of contingent
consideration, and$2.7 million of RYAN Class A common stock.
On December 1, 2023, the Company completed the acquisition of AccuRisk Holdings, LLC (“AccuRisk”), a medical stop
loss managing general underwriter headquartered in Chicago, Illinois, for$98.3 million of cash consideration. During the
year ended December 31, 2024, measurement period adjustments related to the initial valuation of contingent consideration
of$0.3 million and deferred tax assets of$0.4 million were recognized as increases in Goodwill on the Consolidated
The Company recognized acquisition-related expenses, which include advisory, legal, accounting, valuation, and other
costs related to diligence, for the 2023 acquisitions above of$7.1 million during the year ended December 31, 2023, in
General and administrative expense on the Consolidated Statements of Income.
Unaudited Pro Forma Financial Information
The following unaudited pro forma financial information presents the combined results of operations of the Company as if
the 2024 and 2023 acquisitions, excluding Griffin as it is already included in the results of all periods presented, all
occurred on January 1, 2023. The unaudited pro forma financial information is presented for informational purposes only
and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place on the
date indicated or of results that may occur in thefuture. The pre-acquisition Castel and US Assure results included in the
pro forma figures below contain acquisition-related expenses that were not considered pro forma adjustments for the
Company.
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Total revenue | $2,671,660 | $2,410,956 |
| Net income | 167,171 | 68,743 |
The unaudited pro forma financial information includes adjustments of (i) incremental amortization expense on intangible
assets acquired of$77.0 million and$146.4 million for the years ended December 31, 2024 and 2023, respectively, (ii) a
decrease of$24.0 million and an increase of$8.4 million in transaction costs for the years ended December 31, 2024 and
2023, respectively, (iii) incremental financing costs and interest expense resulting from the debt activity related to the US
Assure and Innovisk acquisitions of$20.6 million and$99.0 million for the years ended December 31, 2024 and 2023,
respectively, (iv) an increase of$9.5 million of income tax expense for the year ended December 31, 2023, related to the
2024 CCRs (as defined in Note 18, Income Taxes), with an equal decrease in income tax expense for the year ended
December 31, 2024, and (v) a reduction intax expenses related to the pro forma adjustments of$8.4 million and$26.2
million for the years ended December 31, 2024 and 2023, respectively.
Total consideration for certain acquisitions includes contingent consideration or contingently returnable consideration,
which is generally based on the EBITDA or revenue of the acquired business following a defined period after purchase.
Further information regarding fair value measurements of contingent consideration and contingently returnable
consideration is detailed in Note 15, Fair Value Measurements. The Company recognizes income or loss for the changes in
fair value of estimated contingent consideration and contingently returnable consideration within Change in contingent
consideration, and recognizes accretion of the discount on these assets or liabilities within Interest expense, net, on the
Consolidated Statements of Income. The table below summarizes the amounts recognized:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Change in contingent consideration | $(22,859) | $5,421 | $442 |
| Interest expense, net | 5,472 | 3,052 | 1,991 |
| Total | $(17,387) | $8,473 | $2,433 |
As of December 31, 2024, the aggregate amount of maximum consideration related to acquisitions was$563.1 million
related to contingent consideration and$18.8 million related to contingently returnable consideration.
- RESTRUCTURING
In February 2023, the Company initiated the ACCELERATE 2025 program to enable continued growth, drive innovation,
and deliver sustainable productivity improvements over the long term. The restructuring plan aimed to reduce costs and
increase efficiencies through a focus on optimizing the Company’s operations and technology. In its expanded form, the
restructuring plan was expected to incur total restructuring costs of approximately$110.0 million through December 31,
2024, and is expected to generate annual savings of approximately$60.0 million in 2025. The total expected costs of the
plan included$55.0 million related to operations and technology optimization,$40.0 million related to employee
compensation and benefits, and$15.0 million related to asset impairment and other termination costs. The plan was
completed on December 31, 2024, as anticipated.
The table below presents the restructuring expense incurred:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | Total | |
| Operations and technology optimization | $27,162 | $25,995 | $53,157 |
| Compensation and benefits | 32,217 | 11,320 | 43,537 |
| Asset impairment and other termination costs | 318 | 11,057 | 11,375 |
| Total | $59,697 | $48,372 | $108,069 |
During the years ended December 31, 2024 and 2023, the Company recognized restructuring expenses of$39.9 million and
$22.6 million, respectively, including contractor costs, in Compensation and benefits, and$19.8 million and$25.8 million,
respectively in General and administrative expense on the Consolidated Statements of Income.
The table below presents a summary of changes in the restructuring liability:
| Operations and Technology Optimization | Compensation and Benefits | Asset Impairmentand Other Termination Costs | Total | |
|---|---|---|---|---|
| Balance at December 31, 2023 | $5,886 | $1,080 | $— | $6,966 |
| Accrued costs | 49,885 | 32,217 | 318 | 82,420 |
| Payments | (38,788) | (29,467) | — | (68,255) |
| Non-cash adjustments | — | — | (318) | (318) |
| Balance at December 31, 2024 | $16,983 | $3,830 | $— | $20,813 |
Accrued costs in the table above include both costs expensed and capitalized during the period. As of December 31, 2024
and 2023,$15.3 million and$5.3 million, respectively, of the restructuring liability was included in Accounts payable and
accrued liabilities and$5.5 million and$1.7 million, respectively, was included in Current Accrued compensation on the
- RECEIVABLES AND OTHER CURRENT ASSETS
Receivables
The Company had receivables of$389.8 million and$294.2 million outstanding as of December 31, 2024 and 2023,
respectively, which were recognized within Commissions and fees receivable – net on the Consolidated Balance Sheets.
Commission and fees receivable is net of an allowance for credit losses. The Company’s allowance for credit losses is
based on a combination of factors, including evaluation of historical write-offs, current economic conditions, aging of
balances, and other qualitative and quantitative analyses.
The following table provides a summary of changes in the Company’s allowance for expected credit losses:
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Balance at beginning of period | $2,458 | $1,980 |
| Write-offs | (3,106) | (1,722) |
| Increase in provision | 3,666 | 2,200 |
| Balance at end of period | $3,018 | $2,458 |
Other Current Assets
Major classes of other current assets consisted of the following:
| As of December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Prepaid expenses | $51,701 | $25,762 |
| Insurance recoverable | 20,155 | 20,562 |
| Interest rate cap | 13,936 | — |
| Other current receivables | 24,159 | 15,905 |
| Total Other current assets | $109,951 | $62,229 |
Other current receivables contain service receivables from Geneva Re, Ltd. See Note 17, Related Parties, for further
information regarding related parties. See Note 16, Commitments and Contingencies, for further information on the
insurance recoverable. See Note 13, Derivatives, for further information on the interest rate cap.
- GOODWILL AND OTHER INTANGIBLE ASSETS
The following table provides a summary of goodwill activity:
| Goodwill | |
|---|---|
| Balance at December 31, 2022 | $1,314,984 |
| Acquisitions | 330,977 |
| Impact of exchange rate changes | 521 |
| Balance at December 31, 2023 | $1,646,482 |
| Acquisitions | 999,763 |
| Measurement period adjustments | 4,744 |
| Impact of exchange rate changes | (4,313) |
| Balance at December 31, 2024 | $2,646,676 |
The net carrying amounts of finite-lived intangible assets are shown in the table below:
| As of December 31, 2024 | As of December 31, 2023 | |||||
|---|---|---|---|---|---|---|
| Cost | Accumulated Amortization | Net Carrying Amount | Cost | Accumulated Amortization | Net Carrying Amount | |
| Customer relationships | $2,102,404 | $(710,356) | $1,392,048 | $1,138,875 | $(566,459) | $572,416 |
| Trade names | 32,538 | (25,201) | 7,337 | 23,669 | (22,447) | 1,222 |
| Internally developed software | 103,388 | (27,051) | 76,337 | 56,704 | (19,672) | 37,032 |
| Total | $2,238,330 | $(762,608) | $1,475,722 | $1,219,248 | $(608,578) | $610,670 |
The cost of internally developed software in development but not yet placed in service was$30.8 million and$18.1 million
as of December 31, 2024 and 2023, respectively.
The aggregate amortization expense from finite-lived intangible assets was$157.8 million,$106.8 million, and$103.6
million for the years ended December 31, 2024,2023, and 2022, respectively. The estimated future amortization for finite-
lived intangible assets as of December 31, 2024, was as follows:
| Customer Relationships · Trade Names · Internally Developed Software | |||
|---|---|---|---|
| 2025 | $216,469 | $3,560 | $15,966 |
| 2026 | 191,450 | 2,266 | 16,743 |
| 2027 | 162,056 | 1,511 | 15,843 |
| 2028 | 143,347 | — | 14,441 |
| 2029 | 126,680 | — | 9,450 |
| Thereafter | 552,046 | — | 3,894 |
| Total | $1,392,048 | $7,337 | $76,337 |
- LEASES
The Company has various non-cancelable operating leases with various terms through September 2038, primarily for office
space and office equipment. The following table provides additional information about the Company’s leases:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Lease costs | |||
| Operating lease costs | $31,375 | $36,907 | $32,834 |
| Finance lease costs | — | — | 31 |
| Short-term lease costs | |||
| Operating lease costs | 1,000 | 870 | 598 |
| Finance lease costs | — | — | 10 |
| Sublease income | (514) | (642) | (488) |
| Lease costs – net | $31,861 | $37,135 | $32,985 |
| Cash paid for amounts included in the measurement of lease liabilities | |||
| Operating cash flows used for operating leases | $32,351 | $32,933 | $25,569 |
| Non-cash related activities | |||
| Right-of-use assets obtained in exchange for new operating lease liabilities | 31,487 | 11,771 | 93,029 |
| Amortization of right-of-use assets for operating lease activity | 22,460 | 24,664 | 23,051 |
| Weighted average discount rate (percent) | |||
| Operating leases | 5.4% | 5.1% | 4.8% |
| Finance leases | — | — | 3.2% |
| Weighted average remaining lease term (years) | |||
| Operating leases | 7.6 | 8.2 | 8.5 |
| Finance leases | — | — | 1.9 |
The estimated future minimum payments of operating leases as of December 31, 2024, were as follows:
| 2025 | $30,436 |
| 2026 | 33,505 |
| 2027 | 30,527 |
| 2028 | 25,910 |
| 2029 | 23,868 |
| Thereafter | 79,703 |
| Total undiscounted future lease payments | $223,949 |
| Less: Imputed interest | (42,611) |
| Present value lease liabilities | $181,338 |
The Company hadthree leases with inception dates prior to December 31, 2024, that had not yet commenced as of
December 31, 2024, for a total future estimated lease liability of$12.3 million.
- DEBT
Substantially all of the Company’s debt is carried at outstanding principal balance, less debt issuance costs and any
unamortized discount. The following table is a summary of the Company’s outstanding debt:
| As of December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Term debt | ||
| 7-year term loan facility, periodic interest and quarterly principal payments, Adjusted Term SOFR + 2.25% as of December 31, 2024, Adjusted Term SOFR + 3.00% as of December 31, 2023, matures September 13, 2031 | $1,672,532 | $1,564,718 |
| Senior secured notes | ||
| 8-year senior secured notes, semi-annual interest payments, 4.38%, mature February 1, 2030 | 401,676 | 400,704 |
| 8-year senior secured notes, semi-annual interest payments, 5.88%, mature August 1, 2032 | 1,198,183 | — |
| Revolving debt | ||
| 5-year revolving loan facility, periodic interest payments, Adjusted Term SOFR + up to 2.50% as of December 31, 2024, Adjusted Term SOFR + up to 3.00% as of December 31, 2023, plus commitment fees of 0.25%-0.50%, matures July 30, 2029 | 1,207 | 377 |
| Premium financing notes | ||
| Commercial notes, periodic interest and principal payments, 6.25%, expire May 1, 2025 | 2,673 | — |
| Commercial notes, periodic interest and principal payments, 6.25%, expire June 1, 2025 | 548 | — |
| Commercial notes, periodic interest and principal payments, 6.25%, expire June 21, 2025 | 2,642 | — |
| Commercial notes, periodic interest and principal payments, 5.75%, expired May 1, 2024 | — | 2,251 |
| Commercial notes, periodic interest and principal payments, 5.75%, expired June 1, 2024 | — | 622 |
| Commercial notes, periodic interest and principal payments, 6.00%, expired June 19, 2024 | — | 2,485 |
| Commercial notes, periodic interest and principal payments, 5.75%, expired June 21, 2024 | — | 2,855 |
| Units subject to mandatory redemption | 3,399 | 5,200 |
| Total debt | $3,282,860 | $1,979,212 |
| Less: Short-term debt and current portion of long-term debt | (51,732) | (35,375) |
| Long-term debt | $3,231,128 | $1,943,837 |
The future maturities of long-term debt, which excludes premium financing notes, as of December 31, 2024, were as
| 2025 | $45,869 |
| 2026 | 17,000 |
| 2027 | 17,000 |
| 2028 | 17,000 |
| 2029 | 17,000 |
| Thereafter | 3,218,316 |
| Total repayments | $3,332,185 |
| Less: Unamortized discounts and debt issuance costs | (55,188) |
| Total | $3,276,997 |
Term Loan
The original principal of the Term Loan was$1,650.0 million. As a result of the Seventh Amendment, as defined and
described below, the principal was increased to$1,700.0 million. As of December 31, 2024,$1,700.0 million of the
principal was outstanding,$0.3 million of interest was accrued, and the related unamortized deferred issuance costs were
$27.8 million. As of December 31, 2023,$1,596.4 million of the principal was outstanding,$1.1 million of interest was
accrued, and the related unamortized deferred issuance costs were$32.8 million.
On January 19, 2024, the Company entered into the fifth amendment (the “Fifth Amendment”) to the Credit Agreement. As
a result of the Fifth Amendment, the applicable interest rate of the Term Loan was reduced from Adjusted Term SOFR +
3.00% to Adjusted Term SOFR +2.75% and is no longer subject to a credit spread adjustment. All other material
provisions remain unchanged. The portion of the debt related to the lenders that opted out of the repricing was considered
extinguished and their portion of the legacy debt issuance costs of$0.4 million was written off during the year ended
December 31, 2024, which was recognized in Interest expense, net on the Consolidated Statements of Income.
Additionally, the Company incurred third-party fees related to the repricing of$1.9 million for the year ended
December 31, 2024, which were recognized in Other non-operating loss on the Consolidated Statements of Income.
On September 13, 2024, the Company entered into the seventh amendment (the “Seventh Amendment”) to the Credit
Agreement. As a result of the Seventh Amendment, the principal of the Term Loan was increased to$1,700.0 million, the
applicable interest rate of the Term Loan was reduced from Adjusted Term SOFR +2.75% to Adjusted Term SOFR +
2.25%, the 0.75% floor on Adjusted Term SOFR was reduced to 0.00%, and the maturity date was extended to
September 13, 2031. Incremental debt issuance costs of$11.1 million were incurred and will be amortized over the
extended term of the loan. The portion of the debt related to the lenders that opted out of the Seventh Amendment was
considered extinguished and their portion of the legacy debt issuance costs of$8.3 million was written off during the year
ended December 31, 2024, which was recognized in Interest expense, net on the Consolidated Statements of Income.
Additionally, the Company incurred third-party fees related to the Seventh Amendment of$16.2 million for the year ended
December 31, 2024, which were recognized in Other non-operating loss on the Consolidated Statements of Income.
Revolving Credit Facility
On July 30, 2024, the Company entered into the sixth amendment (the “Sixth Amendment”) to the Credit Agreement,
which provided for an increase in the borrowing capacity of the Revolving Credit Facility from$600.0 million to$1,400.0
million. The Sixth Amendment also extended the maturity date of the Revolving Credit Facility to July 30, 2029, and
reduced the applicable interest rate from Adjusted Term SOFR + up to 3.00% to Adjusted Term SOFR + up to 2.50%.
Incremental debt issuance costs of$7.9 million were incurred and will be amortized over the extended term of the facility.
The portion of the debt related to the lender that opted out of the Sixth Amendment was considered extinguished and its
portion of the legacy debt issuance costs of$0.1 million was written off during the year ended December 31, 2024, which
was recognized in Interest expense, net on the Consolidated Statements of Income.
The Revolving Credit Facility had a borrowing capacity of$1,400.0 million and$600.0 million as of December 31, 2024
and 2023, respectively. Due to the nature of the instrument, the deferred issuance costs related to the facility of$9.6 million
and$4.1 million were included in Other non-current assets on the Consolidated Balance Sheets as of December 31, 2024
and 2023, respectively. The commitments available to be borrowed under the Revolving Credit Facility were$1,399.7
million and$599.7 million as of December 31, 2024 and 2023, respectively, as the facility was reduced by$0.3 million of
undrawn letters of credit.
The Company pays a commitment fee on undrawn amounts under the facility of 0.25% -0.50%. As of December 31, 2024
and 2023, the Company accrued$1.2 million and$0.4 million, respectively, of unpaid commitment fees related to the
Revolving Credit Facility in Short-term debt and current portion of long-term debt on the Consolidated Balance Sheets.
Borrowings under the Term Loan and the Revolving Credit Facility are secured by a first-priority lien and security interest
in substantially all of the assets, subject to certain exceptions, of existing and future material domestic subsidiaries of the
Company.
Senior Secured Notes due 2030
On February 3, 2022, the LLC issued$400.0 million of Senior Secured Notes. As of December 31, 2024 and 2023, accrued
interest on the notes was$7.3 million and the related unamortized deferred issuance costs were$5.6 million and$6.6
million, respectively.
Senior Secured Notes due 2032
On September 19, 2024, the LLC issued$600.0 million of Senior Secured Notes. On December 9, 2024, the LLC issued an
additional$600.0 million aggregate principal amount of Senior Secured Notes at a price of 99.5% of their face value plus
accrued interest from September 19, 2024. The notes issued in December 2024 were issued as additional notes under the
same indenture as the notes that were issued in September 2024 and, as such, form a single series and trade interchangeably
with the previously issued senior secured notes due 2032. As of December 31, 2024, accrued interest on the notes was
$20.0 million and the related unamortized deferred issuance costs, including discount, were$21.8 million.
Bridge Facility
On July 31, 2024, the Company entered into a 364-day unsecured bridge term loan facility (the “Bridge Facility”), which
provided unsecured bridge financing of up to$500.0 million to finance a portion of the US Assure acquisition price. In lieu
of drawing under the Bridge Facility, the Company borrowed under the Revolving Credit Facility. Concurrent with the
completion of the US Assure acquisition on August 30, 2024, the Bridge Facility was terminated, and the Company
recognized$4.1 million of related deferred financing costs in Interest expense, net on the Consolidated Statements of
Income during the year ended December 31, 2024.
Subsidiary Units Subject to Mandatory Redemption
Ryan Re Underwriting Managers, LLC (“Ryan Re”) has the obligation to settle its outstanding preferred units in the
amount of the aggregate unreturned capital and unpaid dividends on June 13, 2034,15 years from original issuance. As
these units are mandatorily redeemable, they are classified as Long-term debt on the Consolidated Balance Sheets. The
historical cost of the units is$3.3 million, which was valued using an implicit rate of 9.8%. Accretion of the discount using
the implicit rate is recognized as Interest expense, net in the Consolidated Statements of Income. As of December 31, 2024
and 2023, interest accrued on these units was $0.1 million and$1.9 million, respectively.$2.1 million of accrued return on
the Ryan Re preferred units was paid during the year ended December 31, 2024. See Note 17, Related Parties, for further
information on Ryan Re.
- STOCKHOLDERS’ EQUITY
Ryan Specialty’s amended and restated certificate of incorporation authorizes the issuance of up to 1,000,000,000 shares of
Class A common stock,1,000,000,000 shares of Class B common stock,10,000,000 shares of Class X common stock, and
500,000,000 shares of preferred stock, each having a par value of$0.001 per share.
The New LLC Operating Agreement requires that the Company and the LLC at all times maintain aone-to-one ratio
between the number of shares of Class A common stock issued by the Company and the number of LLC Common Units
owned by the Company, except as otherwise determined by the Company.
Class A and Class B Common Stock
Each share of Class A common stock is entitled toone vote per share. Each share of Class B common stock is initially
entitled to 10 votes per share but, upon the occurrence of certain events as set forth in the Company’s amended and restated
certificate of incorporation, will be entitled toone vote per share in the future. All holders of Class A common stock and
Class B common stock vote together as a single class except as otherwise required by applicable law or our amended and
restated certificate of incorporation. Holders of Class B common stock do not have any right to receive dividends or
distributions upon the liquidation or winding up of the Company.
In accordance with the New LLC Operating Agreement, the LLC Unitholders are entitled to exchange LLC Common Units
for shares of Class A common stock, in accordance with the LLC Operating Agreement, or, at the Company’s election, for
cash from a substantially concurrent public offering or private sale (based on the price of our Class A common stock in
such public offering or private sale). The LLC Unitholders are also required to deliver to the Company an equivalent
number of shares of Class B common stock to effectuate such an exchange. Any shares of Class B common stock so
delivered will be canceled. Shares of Class B common stock are not issued for Class C Incentive Units that are exchanged
for LLC Common Units as these LLC Common Units are immediately exchanged for Class A common stock as discussed
in Note 11, Equity-Based Compensation.
Class X Common Stock
There wereno shares of Class X common stock outstanding as of December 31, 2024 or 2023. Shares of Class X common
stock have no economic or voting rights.
Preferred Stock
There wereno shares of preferred stock outstanding as of December 31, 2024 or 2023. Under the terms of the amended and
restated certificate of incorporation, the Board is authorized to direct the Company to issue shares of preferred stock in one
or more series without stockholder approval. The Board has the discretion to determine the rights, preferences, privileges,
and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation
preferences, of each series of preferred stock.
Dividends
During the year ended December 31, 2024, the Company’s Board of Directors declared a regular quarterly cash dividend of
$0.11 per share on the Company’s outstanding Class A common stock. During the year ended December 31, 2024,$80.2
million of dividends, consisting of$27.1 million related to the special Q1 2024 dividend and$53.1 million related to
regular quarterly dividends, was paid on Class A common stock.
Non-controlling Interests
The Company is the sole managing member of the LLC. As a result, the Company consolidates the LLC in its consolidated
financial statements, resulting in non-controlling interests related to the LLC Common Units not held by the Company. As
of December 31, 2024 and 2023, the Company owned 47.9% and 45.6%, respectively, of the economic interests in the
LLC, while the non-controlling interest holders owned the remaining 52.1% and 54.4%, respectively, of the economic
interests in the LLC.
Weighted average ownership percentages for the applicable reporting periods are used to attribute net income and other
comprehensive income (loss) to the Company and the non-controlling interest holders. The non-controlling interest
holders’ weighted average ownership percentage was 52.0%,56.1%, and 57.1% for the years ended December 31, 2024,
2023, and 2022, respectively.
During the year ended December 31, 2024, the Company declared a regular quarterly cash distribution of$0.04 per unit on
the LLC’s outstanding LLC Common Units. During the year ended December 31, 2024,$22.2 million in distributions were
paid to the non-controlling interest holders of the LLC Common Units
- EQUITY-BASED COMPENSATION
The Ryan Specialty Holdings, Inc., 2021 Omnibus Incentive Plan (the “Omnibus Plan”) governs, among other things, the
types of awards the Company can grant to employees as equity-based compensation awards. The Omnibus Plan provides
for potential grants of the following awards: (i) stock options, (ii) stock appreciation rights, (iii) restricted stock awards,
(iv) performance awards, (v) other stock-based awards, (vi) other cash-based awards, and (vii) analogous equity awards
made in equity of the LLC.
IPO-Related Awards
As a result of the Organizational Transactions, pre-IPO holders of LLC Units that were granted as incentive awards, which
had historically been classified as equity and vested pro rata over five years, were required to exchange their LLC Units for
either Restricted Stock or Restricted Common Units. Additionally, Reload Options or Reload Class C Incentive Units were
issued to employees in order to protect against the dilution of their existing awards upon exchange to the new awards.
Separately, certain employees were granted one or more of the following new awards: (i)RSUs, (ii) Staking Options, (iii)
RLUs, or (iv) Staking Class C Incentive Units. The terms of these awards are described below. All awards granted as part
of the Organizational Transactions and the IPO are subject to non-linear transfer restrictions for at least thefive-year period
following the IPO.
Incentive Awards
As part of the Company’s annual compensation process, the Company issues certain employees and directors equity-based
compensation awards (“Incentive Awards”). Additionally, the Company offers Incentive Awards to certain new hires.
These Incentive Awards typically take the form of (i) RSUs, (ii) RLUs, (iii) Class C Incentive Units, (iv) Stock Options,
(v)PSUs, and (vi) PLUs. The terms of these awards are described below.
Restricted Stock and Restricted Common Units
As part of the Organizational Transactions, certain existing employee unitholders were granted Restricted Stock or
Restricted Common Units in exchange for their LLC Units. The Restricted Stock and Restricted Common Units follow the
vesting schedule of the LLC Units for which they were exchanged. LLC Units historically vested pro rata over 5 years.
| Restricted Stock | Weighted Average Grant Date Fair Value | Restricted Common Units | Weighted Average Grant Date Fair Value | |
|---|---|---|---|---|
| Unvested at beginning of period | 938,910 | $21.15 | 1,122,564 | $23.84 |
| Granted | — | — | — | — |
| Vested | (516,679) | 21.15 | (986,573) | 23.84 |
| Forfeited | (8,411) | 21.15 | — | — |
| Unvested at end of period | 413,820 | $21.15 | 135,991 | $23.84 |
Restricted Stock Units (RSUs)
IPO RSUs
Related to the IPO, the Company granted RSUs to certain employees. The IPO RSUs vest either pro rata over 5 years from
the grant date or over 10 years from the grant date, with 10% vesting in each of years 3 through 9 and 30% vesting in year
Incentive RSUs
As part of the Company’s compensation process, the Company issues Incentive RSUs to certain employees. The Incentive
RSUs vest either 100% 3 or 5 years from the grant date, pro rata over 3 or 5 years from the grant date, over 5 years from
the grant date, with one-third of the grant vesting in each of years 3,4 and 5, or over 7 years from the grant date, with 20%
vesting in each of years 3 through 7.
Upon vesting, RSUs automatically convert on aone-for-one basis into Class A common stock.
| IPO RSUs | Incentive RSUs | |||
|---|---|---|---|---|
| Restricted Stock Units | Weighted Average Grant Date Fair Value | Restricted Stock Units | Weighted Average Grant Date Fair Value | |
| Unvested at beginning of period | 3,359,778 | $23.07 | 1,819,916 | $38.02 |
| Granted | — | — | 834,362 | 53.39 |
| Vested | (608,355) | 22.80 | (199,772) | 38.02 |
| Forfeited | (51,457) | 22.69 | (79,819) | 40.90 |
| Unvested at end of period | 2,699,966 | $23.14 | 2,374,687 | $43.33 |
The weighted-average grant date fair value of Incentive RSUs granted during the years ended December 31, 2023 and
2022, was$41.37 and$34.63, respectively. The fair value of RSUs vested during the years ended December 31, 2024,
2023, and 2022, was$46.2 million,$19.8 million, and$19.7 million, respectively.
Stock Options
Reload and Staking Options
As part of the Organizational Transactions and IPO, certain employees were granted Reload Options or Staking Options
that entitle the award holder to future purchases of Class A common stock, on aone-for-one basis, at the IPO price of
$23.50. The Reload Options vest either 100% 3 years from the grant date or over 5 years from the grant date, with one-
third of the grant vesting in each of years 3,4 and 5. In general, vested Reload Options are exercisable up to the tenth
anniversary of the grant date. The Staking Options vest over 10 years from the grant date, with 10% vesting in each of
years 3 through 9 and 30% vesting in year 10. In general, vested Staking Options are exercisable up to the eleventh
anniversary of the grant date.
Incentive Options
As part of the Company’s compensation process, the Company may issue Incentive Options to certain employees that
entitle the award holder to future purchases of Class A common stock, on aone-for-one basis, at the respective exercise
prices. The Incentive Options vest either over 5 years from the grant date, with one-third of the grant vesting in each of
years 3,4 and 5 or pro rata over 7 years from the grant date. In general, vested Incentive Options are exercisable up to the
tenth anniversary of the grant date.
| Reload Options1 | Staking Options1 | Incentive Options | Incentive Options Weighted Average Exercise Price | |
|---|---|---|---|---|
| Outstanding at beginning of period | 4,473,388 | 66,667 | 165,684 | $34.39 |
| Granted | — | — | 150,000 | 52.38 |
| Exercised | (550,294) | — | — | — |
| Forfeited | (52,330) | — | (34,032) | 34.39 |
| Outstanding at end of period | 3,870,764 | 66,667 | 281,652 | $43.97 |
1 As the Reload and Staking Options were one-time grants at the IPO, the weighted average exercise price for any
movements in these awards will perpetually be$23.50. As such, the values are not presented in the table above.
The fair valuesof Incentive Options granted were determined using the Black-Scholes option pricing model with the
following assumptions:
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2022 | |
| Volatility | 25.0% | 27.5% |
| Time to maturity (years) | 7.0 | 7.0 |
| Risk-free rate | 4.2% | 2.2% |
| Dividend yield | 0.8% | 0.0% |
| Fair value per option | $17.09 | $11.68 |
There wereno Incentive Options granted during the year ended December 31, 2023.
The use of a valuation model for the Options requires management to make certain assumptions with respect to selected
model inputs. Expected volatility was calculated based on the observed volatility for comparable companies. The expected
times to maturity were based on the weighted-average vesting terms and contractual terms of the awards. The risk-free
interest rates were based on U.S. Treasury rates commensurate with the expected life of the respective award. The dividend
yields were based on the Company’s expected dividend rates.
As of December 31, 2024, there were 6,666 and 1,557,285 exercisable Staking and Reload Options, respectively, andno
exercisable Incentive Options. The aggregate intrinsic values and weighted average remaining contractual terms of Stock
Options outstanding and exercisable as of December 31, 2024, were as follows:
| Aggregate intrinsic value ($ in thousands): | |
|---|---|
| Reload Options outstanding | $157,385 |
| Reload Options exercisable | 63,319 |
| Staking Options outstanding | 2,711 |
| Staking Options exercisable | 271 |
| Incentive Options outstanding | 5,686 |
| Incentive Options exercisable | — |
| Weighted-average remaining contractual term (in years): | |
| Reload Options outstanding | 6.3 |
| Reload Options exercisable | 6.2 |
| Staking Options outstanding | 7.6 |
| Staking Options exercisable | 7.6 |
| Incentive Options outstanding | 8.2 |
| Incentive Options exercisable | — |
Restricted LLC Units (RLUs)
IPO RLUs
Related to the IPO, the Company granted RLUs to certain employees that vest either pro rata over 5 years from the grant
date or over 10 years from the grant date, with 10% vesting in each of years 3 through 9 and 30% vesting in year 10.
Incentive RLUs
As part of the Company’s compensation process, the Company issues Incentive RLUs to certain employees. The Incentive
RLUs vest either 100% 3 years from the grant date, pro rata over 3 or 5 years from the grant date, or over 7 years from the
grant date, with 20% vesting in each of years 3 through 7.
Upon vesting, RLUs convert on aone-for-one basis into either LLC Common Units or Class A common stock at the
election of the Company.
| IPO RLUs | Incentive RLUs | |||
|---|---|---|---|---|
| Restricted LLC Units | Weighted Average Grant Date Fair Value | Restricted LLC Units | Weighted Average Grant Date Fair Value | |
| Unvested at beginning of period | 1,448,127 | $25.09 | 482,329 | $39.80 |
| Granted | — | — | 249,971 | 51.33 |
| Vested | (154,589) | 25.05 | (45,588) | 35.60 |
| Forfeited | — | — | — | — |
| Unvested at end of period | 1,293,538 | $25.10 | 686,712 | $44.30 |
The weighted-average grant date fair value of Incentive RLUs granted during the years ended December 31, 2023 and
2022, was$41.14 and$34.86, respectively.
Class C Incentive Units
Reload and Staking Class C Incentive Units
As part of the Organizational Transactions and IPO, certain employees were granted Reload Class C Incentive Units or
Staking Class C Incentive Units, which are profits interests. When the value of Class A common stock exceeds the
participation threshold, vested profits interests may be exchanged for LLC Common Units of equal value. On exchange,
the LLC Common Units are immediately redeemed on a one-for-one basis for Class A common stock. The Reload Class C
Incentive Units vest either 100% 3 years from the grant date or over 5 years from the grant date, with one-third of the grant
vesting in each of years 3,4 and 5. The Staking Class C Incentive Units vest either pro rata over 5 years from the grant date
or over 10 years from the grant date, with 10% vesting in each of years 3 through 9 and 30% vesting in year 10.
Class C Incentive Units
As part of the Company’s compensation process, the Company issues Class C Incentive Units to certain employees, which
are profits interests. When the value of Class A common stock exceeds the participation threshold, vested profits interests
may be exchanged for LLC Common Units of equal value. On exchange, the LLC Common Units are immediately
redeemed on a one-to-one basis for Class A common stock. The Class C Incentive Units vest over 8 years from the grant
date, with 15% vesting in each of years 3 through 7 and 25% vesting in year 8, or over 7 years from the grant date, with
20% vesting in each of years 3 through 7.
| Reload Class C Incentive Units | Staking Class C Incentive Units | Class C Incentive Units | Class C Incentive Units Weighted Average Participation Threshold | |
|---|---|---|---|---|
| Unvested at beginning of period | 3,911,490 | 1,876,669 | 495,822 | $36.96 |
| Granted | — | — | — | — |
| Vested | (2,958,895) | (271,666) | — | — |
| Forfeited | — | — | — | — |
| Unvested at end of period | 952,595 | 1,605,003 | 495,822 | $36.80 |
As the Reload and Staking Class C Incentive Units were one-time grants at the IPO, the weighted average participation
threshold for these awards will be consistent across any type of movement. The weighted average participation threshold
for Reload and Staking Class C Incentive Units was$23.34 and$23.50 as of December 31, 2024 and 2023, respectively.
The decrease in the participation thresholds for the various types of Class C Incentive Units was due to the distributions
declared with respect to these awards during the year ended December 31, 2024.
Valuation Considerations
The Restricted Common Units, once vested, are exchangeable into shares of Class A common stock of the Company on a
one-to-one basis, which entitles the unitholders to TRA payments resulting from 85% of the tax savings generated by the
Company. The various Class C Incentive Units have the same terms as the LLC Common Units, with the exception of their
respective participation thresholds. When the price of the Class A common stock exceeds the participation threshold, the
Class C Incentive Units can be exchanged for LLC Common Units of equal value and are entitled to the same TRA
benefits upon an exchange to Class A common stock. In order to value the Restricted Common Units and Class C Incentive
Units the Company is required to make certain assumptions with respect to select model inputs.
Due to the nature of the underlying risks inherent in TRA payments and the uncertainty as to when the participation
threshold will be satisfied for the various Class C Incentive Units, the Company uses a Monte Carlo simulation to explicitly
model the impact of future stock prices on the size of the amortizable asset, as well as the impact of different levels of
taxable income on the timing of the TRA payments, in a risk-neutral framework. For Class C Incentive Units granted
during the years ended December 31, 2023 and 2022, the Monte Carlo simulation model used the following assumptions:
the simulated closing stock price, the simulated taxable income, the risk-free interest rate, the expected dividend yield, and
the expected volatility and correlation of the Company’s stock price and taxable income. The dividend yield was based on
the Company’s expected dividend rate of 0.0%. The risk-free interest rate range of 2.4%-4.0% was based on U.S. Treasury
rates commensurate with a term of 30 years. The weighted-average grant date fair value of Class C Incentive Units granted
during the years ended December 31, 2023 and 2022, was$22.98 and$19.04, respectively.
Performance Based Awards
Performance Stock Units (PSUs) and Performance LLC Units (PLUs)
Certain employees were granted performance-based equity awards, either PSUs or PLUs, subject to the Company’s
achievement of several defined performance metrics including (i) an Adjusted EBITDAC Margin target, (ii) an Organic
Revenue Growth Compound Annual Growth Rate (“CAGR”) target, and (iii) total shareholder return (“TSR”) CAGR
targets. The TSR CAGR targets are measured from the$52.38 base price of Class A common stock to the sum of (i) the
average of (a) the volume weighted average price (“VWAP”) of the Class A common stock for the fourth quarter of 2027
and (b) the VWAP of the Class A common stock for the first quarter of 2028 and (ii) dividends paid to Class A common
shareholders. The Adjusted EBITDAC Margin and the Organic Revenue Growth CAGR targets, as well as a minimum
threshold for the TSR CAGR target, must be achieved for the awards to vest. If the Adjusted EBITDAC Margin or the
Organic Revenue Growth CAGR targets are not met, or the TSR CAGR is below the minimum threshold, the awards will
be forfeit.
PSUs represent the right to receive Class A common shares and PLUs represent the right to receive LLC Common Units
upon vesting. If the Adjusted EBITDAC Margin and the Organic Revenue Growth CAGR targets are achieved, and the
TSR CAGR meets at least the minimum threshold, the TSR CAGR targets will determine how many Class A common
shares or LLC Common Units, as applicable, the awards vest into. Assuming the minimum threshold is met, the awards
will vest into between 75% and 150% of the applicable stock or units. The payout percentage between the TSR CAGR
range will be determined on a graduated basis. Confirmation of the targets will not occur until after the Company’s fiscal
year 2028 earnings are reported. If the targets are achieved, the awards will vest on April 1, 2029. The probability of
achieving the performance metrics is assessed each reporting period for expense purposes.
| PSUs · PLUs | ||||
|---|---|---|---|---|
| Performance Stock Units | Weighted Average Grant Date Fair Value | Performance LLC Units | Weighted Average Grant Date Fair Value | |
| Unvested at beginning of period | — | $— | — | $— |
| Granted | 366,996 | 27.99 | 487,218 | 24.40 |
| Vested | — | — | — | — |
| Forfeited | — | — | — | — |
| Unvested at end of period | 366,996 | $27.99 | 487,218 | $24.40 |
The fair values of the performance-based awards granted during the year ended December 31, 2024, were determined using
the Monte Carlo simulation valuation model with the following assumptions:
| PSUs and PLUs | |
|---|---|
| Volatility | 22.1% - 24.7% |
| Time to maturity (years) | 3.4 - 4.1 |
| Risk-free rate | 4.1% - 4.2% |
| RYAN stock price at valuation date | $52.38 - $66.71 |
The use of a valuation model for the PSUs and PLUs requires management to make certain assumptions with respect to
selected model inputs. Expected volatility was calculated based on the observed volatility for comparable companies. The
time to maturity was based on the stock price CAGR target through the first quarter of 2028. The risk-free interest rate was
based on U.S. Treasury rates commensurate with the performance period. The difference in the grant date fair value of the
PSUs and PLUs relates to the difference in Dividend Equivalents and Distributions Declared (as defined below) each
award is entitled to accrue.
Non-Employee Director Stock Grants
The Company grants RSUs to non-employee directors serving as members of the Company’s Board of Directors (“Director
Stock Grants”), with the exception ofone director who has agreed to forgo any compensation for their service to the Board.
The Director Stock Grants are fully vested upon grant. During the years ended December 31, 2024,2023, and 2022, the
Company granted 22,935,19,698, and 53,159 Director Stock Grants, respectively, with weighted-average grant date fair
values of$49.07,$40.86, and$36.30, respectively.
Dividend Equivalents and Declared Distributions
A majority of the Company’s unvested equity-based compensation awards, with the exception of Options and Class C
Incentive Units, are entitled to accrue dividend equivalents if the award vests into Class A common stock (“Dividend
Equivalents”) or declared distributions if the award vests into LLC Common Units (“Declared Distributions”) over the
period the underlying award vests. The Dividend Equivalents and Declared Distributions will be paid in cash to award
holders at the time the underlying award vests. If an award holder forfeits their underlying award, the accrued Dividend
Equivalents or Declared Distributions will also be forfeit. Class C Incentive Units do not accrue cash distributions but
instead have their participation thresholds lowered by each declared distribution. Options do not participate in dividends.
As of December 31, 2024, the Company accrued$0.9 million and$0.1 million related to Dividend Equivalents and
Declared Distributions, respectively, in Accounts payable and accrued liabilities, and$2.9 million and$0.4 million related
to Dividend Equivalents and Declared Distributions, respectively, in Other non-current liabilities on the Consolidated
Equity-Based Compensation Expense
As of December 31, 2024, the unrecognized equity-based compensation expense related to each type of equity-based
compensation award described above and the related weighted-average remaining expense period were as follows:
| Amount | Weighted AverageRemaining ExpensePeriod (Years) | |
|---|---|---|
| Restricted Stock | $896 | 0.4 |
| IPO RSUs | 27,358 | 3.3 |
| Incentive RSUs | 56,548 | 2.3 |
| Reload Options | 951 | 0.6 |
| Staking Options | 236 | 3.7 |
| Incentive Options | 2,230 | 1.5 |
| PSUs | 8,866 | 4.0 |
| Restricted Common Units | 458 | 0.1 |
| IPO RLUs | 16,817 | 4.6 |
| Incentive RLUs | 19,278 | 1.8 |
| Reload Class C Incentive Units | 626 | 0.8 |
| Staking Class C Incentive Units | 9,035 | 4.1 |
| Class C Incentive Units | 5,362 | 3.6 |
| PLUs | 9,829 | 4.0 |
| Total unrecognized equity-based compensation expense | $158,490 |
The following table includes the equity-based compensation the Company recognized by award type from the view of
expense related to pre-IPO and post-IPO awards. The table also presents the unrecognized equity-based compensation
expense as of December 31, 2024, in the same view.
| Recognized · Unrecognized | ||||
|---|---|---|---|---|
| Year Ended December 31, · As of | ||||
| 2024 | 2023 | 2022 | December 31, 2024 | |
| IPO awards | ||||
| IPO RSUs and Staking Options | $11,522 | $15,760 | $22,700 | $27,594 |
| IPO RLUs and Staking Class C Incentive Units | 9,284 | 11,424 | 12,561 | 25,852 |
| Incremental Restricted Stock and Reload Options | 2,820 | 4,332 | 7,126 | 1,399 |
| Incremental Restricted Common Units and Reload Class C Incentive Units | 3,328 | 7,119 | 11,705 | 947 |
| Pre-IPO incentive awards | ||||
| Restricted Stock | 1,473 | 2,387 | 4,860 | 448 |
| Restricted Common Units | 5,170 | 1,454 | 3,079 | 137 |
| Post-IPO incentive awards | ||||
| Incentive RSUs | 29,769 | 19,245 | 7,417 | 56,548 |
| Incentive RLUs | 7,728 | 4,567 | 2,148 | 19,278 |
| Incentive Options | 974 | 466 | 431 | 2,230 |
| Class C Incentive Units | 2,072 | 1,906 | 873 | 5,362 |
| PSUs | 1,407 | — | — | 8,866 |
| PLUs | 2,058 | — | — | 9,829 |
| Other expense | ||||
| Director Stock Grants | 1,390 | 1,083 | 2,000 | — |
| Profit sharing contribution | — | — | 2,580 | — |
| Total equity-based compensation expense | $78,995 | $69,743 | $77,480 | $158,490 |
- EARNINGS PER SHARE
Basic earnings per share is computed by dividing net earnings attributable to Ryan Specialty Holdings, Inc., by the
weighted-average number of shares of Class A common stock outstanding during the period. Diluted earnings per share is
computed giving effect to potentially dilutive shares, including LLC equity awards and the non-controlling interests’ LLC
Common Units that are exchangeable into Class A common stock. As shares of Class B common stock do not share in
earnings and are not participating securities, they are not included in the Company’s calculation. A reconciliation of the
numerator and denominator used in the calculation of basic and diluted earnings per share of Class A common stock is as
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net income | $229,913 | $194,480 | $163,257 |
| Less: Net income attributable to non-controlling interests | 135,248 | 133,443 | 102,205 |
| Net income attributable to Ryan Specialty Holdings, Inc. | $94,665 | $61,037 | $61,052 |
| Numerator: | |||
| Net income attributable to Class A common shareholders | $94,665 | $61,037 | $61,052 |
| Add (less): Income attributed to substantively vested RSUs | — | (10) | 806 |
| Net income attributable to Class A common shareholders – basic | $94,665 | $61,027 | $61,858 |
| Add: Income attributed to dilutive shares | 255 | 4,185 | 75,512 |
| Net income attributable to Class A common shareholders – diluted | $94,920 | $65,212 | $137,370 |
| Denominator: | |||
| Weighted-average shares of Class A common stock outstanding – basic | 120,781,234 | 114,359,968 | 108,616,420 |
| Add: Dilutive shares | 12,110,253 | 11,385,171 | 157,134,024 |
| Weighted-average shares of Class A common stock outstanding – diluted | 132,891,487 | 125,745,139 | 265,750,444 |
| Earnings per share | |||
| Earnings per share of Class A common stock – basic | $0.78 | $0.53 | $0.57 |
| Earnings per share of Class A common stock – diluted | $0.71 | $0.52 | $0.52 |
The following shares were excluded from the calculation of diluted earnings per share because the effect of including such
potentially dilutive shares would have been antidilutive:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Conversion of non-controlling interest LLC Common Units1 | 138,979,885 | 142,383,621 | — |
| Conversion of vested Class C Incentive Units1 | — | 76,397 | — |
| Class C Incentive Units | — | 495,822 | 300,000 |
| Incentive Options | — | — | 170,392 |
1 Weighted average units outstanding during the period.
- DERIVATIVES
Deal-Contingent Foreign Currency Forward
On December 21, 2023, the Company entered into the Deal-Contingent Forward to manage the risk of appreciation of the
GBP-denominated purchase price of the acquisition of Castel. The Deal-Contingent Forward had a 200.0 million GBP
notional amount and was executed when the Castel acquisition closed on May 1, 2024. As the Deal-Contingent Forward
was an economic hedge and had not been designated as an accounting hedge, losses resulting from the Deal-Contingent
Forward were recognized through earnings in the periods incurred.
Interest Rate Cap
In April 2022, the Company entered into an interest rate cap agreement to manage its exposure to interest rate fluctuations
related to the Company’s Term Loan in the amount of$25.5 million. The interest rate cap has a$1,000.0 million notional
amount,2.75% strike, and terminates on December 31, 2025. At inception, the Company formally designated the interest
rate cap as a cash flow hedge. As of December 31, 2024, the interest rate cap continued to be an effective hedge.
For the years ended December 31, 2024 and 2023, decreases of$15.7 million and$16.2 million, respectively, in the fair
value of the interest rate cap were recognized in Other comprehensive income (loss). For the year ended December 31,
2022, an increase of$20.4 million in the fair value of the interest rate cap was recognized in Other comprehensive income
(loss). As of December 31, 2024, the Company expects$13.9 million of unrealized gains from the interest rate cap to be
reclassified into earnings over the next twelve months. See Note 18, Income Taxes, for further information on the tax
effects on other comprehensive income related to the interest rate cap.
The location and gains (losses) on derivatives are reported on the Consolidated Statements of Income as follows:
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| Income Statement Caption · 2024 · 2023 · 2022 | ||||||
| Change in the fair value of the Deal-Contingent Forward | General and administrative | $(4,532) | $(852) | $— | ||
| Total impact of derivatives not designated as hedging instruments | $(4,532) | $(852) | $— | |||
| Interest rate cap premium amortization | Interest expense, net | $(6,955) | $(6,955) | $(4,636) | ||
| Amounts reclassified out of other comprehensive income related to the interest rate cap | Interest expense, net | 24,723 | 22,900 | 2,174 | ||
| Total impact of derivatives designated as hedging instruments | $17,768 | $15,945 | $(2,462) | |||
The location and fair value of derivatives are reported on the Consolidated Balance sheets as follows:
| As of December 31, | |||
|---|---|---|---|
| Balance Sheet Caption | 2024 | 2023 | |
| Derivatives not designated as hedging instruments | |||
| Deal-Contingent Forward | Accounts payable and accrued liabilities | $— | $852 |
| Derivatives designated as hedging instruments | |||
| Interest rate cap | Other current assets | $13,936 | $— |
| Interest rate cap | Other non-current assets | $— | $29,667 |
See Note 15, Fair Value Measurements, for further information on the fair value of derivatives.
- VARIABLE INTEREST ENTITIES
As discussed in Note 1, Basis of Presentation, the Company consolidates the LLC as a VIE under ASC 810. The
Company’s financial position, financial performance, and cash flows effectively represent those of the LLC as of and for
the year ended December 31, 2024, with the exception of Cash and cash equivalents of$27.2 million, Other current assets
of$15.4 million, Deferred tax assets of$448.1 million, Accounts payable and accrued liabilities of$0.9 million, Other
non-current liabilities of$2.9 million, and the entire balance of the Tax Receivable Agreement liabilities of$436.3 million
on the Consolidated Balance Sheets, which are attributable solely to Ryan Specialty Holdings, Inc. As of December 31,
2023, Cash and cash equivalents of$58.2 million, Deferred tax assets of$383.3 million, and the entire balance of the Tax
Receivable Agreement liabilities of$358.9 million on the Consolidated Balance Sheet were attributable solely to Ryan
Specialty Holdings, Inc.
- FAIR VALUE MEASUREMENTS
Accounting standards establish a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair values as
Level 1: Observable inputs such as quoted prices for identical assets in active markets;
Level 2: Inputs other than quoted prices for identical assets in active markets, that are observable either directly or
indirectly; and
Level 3: Unobservable inputs in which there is little or no market data which requires the use of valuation techniques and
the development of assumptions.
The level in the fair value hierarchy within which the fair value measurement is classified is determined based on the
lowest level of input that is significant to the fair value measure in its entirety.
The carrying amount of financial assets and liabilities reported on the Consolidated Balance Sheets for commissions and
fees receivable—net, other current assets, accounts payable, short-term debt, and other accrued liabilities as of
December 31, 2024 and 2023, approximate fair value because of the short-term duration of these instruments. The fair
value of long-term debt, including the Term Loan, Senior Secured Notes, the units subject to mandatory redemption, and
any current portion of such debt, was$3,275.1 million and$1,976.5 million as of December 31, 2024 and 2023,
respectively. The fair value of the Term Loan and Senior Secured Notes would be classified as Level 2 in the fair value
hierarchy and the units subject to mandatory redemption would be classified as Level 3. See Note 9, Debt, for the carrying
values of the Company’s debt.
Derivative Instruments
Deal-Contingent Foreign Currency Forward
The Company entered into the Deal-Contingent Forward to manage the risk of appreciation of the GBP-denominated
purchase price of the Castel acquisition. The fair value of the Deal-Contingent Forward was determined by comparing the
contractual foreign exchange rates to forward market rates for various future dates, probability weighted for when the
acquisition was anticipated to close, and discounted to the valuation date. The lowest level of inputs used that were
significant in determining the fair value were considered Level 3 inputs. See Note 13, Derivatives, for further information
on the Deal-Contingent Forward.
Interest Rate Cap
The Company uses an interest rate cap to manage its exposure to interest rate fluctuations related to the Company’s Term
Loan. The fair value of the interest rate cap is determined using the market standard methodology of discounting the future
expected cash receipts that would occur if variable interest rates rise above the strike rate of the cap. The variable interest
rates used in the calculation of projected receipts on the cap are based on an expectation of future interest rates derived
from observable market interest rate curves and volatilities. The inputs used in determining the fair value of the interest rate
cap are considered Level 2 inputs. See Note 13, Derivatives, for further information on the interest rate cap.
The fair values of contingent consideration and contingently returnable consideration are based on the present value of the
future expected payments to be made to the sellers and to be received from the sellers, respectively, of certain acquired
businesses in accordance with the provisions outlined in the respective purchase agreements, which are Level 3 fair value
measurements. In determining fair value, the Company estimates cash payments and receipts based on management’s
financial projections of the performance of each acquired business relative to the formula specified by each purchase
agreement. The Company utilizes Monte Carlo simulations to evaluate financial projections of each acquired business. The
Monte Carlo models consider forecasted revenue and EBITDA and market risk adjusted revenue and EBITDA, which are
run through a series of simulations. As of December 31, 2024, the models used risk-free rates, expected volatility, and a
credit spread that ranged from 3.5% to 5.4%,6.8% to 18.7%, and 0.7% to 2.6%, respectively. As of December 31, 2023,
the models used risk-free rates, expected volatility, and a credit spread that ranged from 4.9% to 5.4%,7.0% to 21.7%, and
3.3% to 4.2%, respectively. The Company discounts the expected payments created by the Monte Carlo model to present
value using a risk-adjusted rate that takes into consideration the market-based rates of return that reflect the ability of the
acquired entity to achieve its targets. The discount rate ranges used to present value the cash payments as of December 31,
2024 and 2023, were 5.0% to 6.6% and 8.3% to 9.1%, respectively.
Each period, the Company revalues the contingent consideration and contingently returnable consideration associated with
certain prior acquisitions to their fair value and records the related changes of the fair value in Change in contingent
consideration in the Consolidated Statements of Income. Changes in contingent consideration result from changes in the
assumptions regarding probabilities of successful achievement of related EBITDA and revenue milestones, the estimated
timing in which milestones are achieved, and the discount rate used to estimate the fair value of the liability. Contingent
consideration may change significantly as the Company’s revenue growth rate and EBITDA estimates evolve and
additional data is obtained, impacting the Company’s assumptions. The use of different assumptions and judgments could
result in a materially different estimate of fair value which may have a material impact on the results from operations and
financial position. See Note 4, Mergers and Acquisitions, for further information on contingent consideration.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents information about the Company’s assets and liabilities measured at fair value on a recurring
basis by fair value hierarchy input level:
| As of December 31, 2024 | As of December 31, 2023 | |||||
|---|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |
| Assets: | ||||||
| Interest rate cap | $— | $13,936 | $— | $— | $29,667 | $— |
| Contingently returnable consideration | — | — | 5,483 | — | — | — |
| Liabilities: | ||||||
| Contingent consideration | — | — | 129,059 | — | — | 41,050 |
| Deal-Contingent Forward | — | — | — | — | — | 852 |
| Total assets and liabilities measured at fair value | $— | $13,936 | $134,542 | $— | $29,667 | $41,902 |
Contingently returnable consideration of$1.3 million and$4.2 million was recorded in Other current assets and Other non-
current assets, respectively, on the Consolidated Balance Sheets as of December 31, 2024. Contingent consideration of
$48.2 million was recorded in Accounts payable and accrued liabilities on the Consolidated Balance Sheets as of
December 31, 2024. Contingent consideration of$80.9 million and$41.1 million was recorded in Other non-current
liabilities on the Consolidated Balance Sheets as of December 31, 2024 and 2023, respectively.
Level 3 Assets and Liabilities Measured at Fair Value
The following is a reconciliation of the beginning and ending balances of the Level 3 assets and liabilities measured at fair
value:
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Balance at beginning of period | $— | $— |
| Newly established assets due to acquisitions | 4,868 | — |
| Total gains included in earnings | 684 | — |
| Total losses included in OCI | (69) | — |
| Balance at end of period | $5,483 | $— |
| Liabilities | ||
| Balance at beginning of period | $41,902 | $29,251 |
| Newly established liabilities due to acquisitions | 103,769 | 11,238 |
| Newly established liability due to derivatives | — | 852 |
| Other (gains) losses included in earnings | (12,171) | 8,473 |
| Settlements | (5,384) | (7,912) |
| Acquisition measurement period adjustments | 943 | — |
| Balance at end of period | $129,059 | $41,902 |
For the year ended December 31, 2023, newly established liabilities due to acquisitions included$8.1 million of contingent
consideration established for the 2023 acquisitions and$3.1 million of acquired contingent consideration arrangements. For
the year ended December 31, 2024,$5.4 million related to the loss on the settlement of the Deal-Contingent Forward is
presented in the operating section of the Consolidated Statements of Cash Flows. For the year ended December 31, 2023,
$3.4 million and$4.5 million settlements of contingent consideration are presented in the operating and financing sections,
respectively, of the Consolidated Statements of Cash Flows.
- COMMITMENTS AND CONTINGENCIES
Legal – E&O and Other Considerations
As an E&S and Admitted markets intermediary, the Company faces ordinary course of business E&O exposure. The
Company also has potential E&O risk if an insurance carrier with which Ryan Specialty placed coverage denies coverage
for a claim or pays less than the insured believes is the full amount owed. The Company seeks to resolve, through
commercial accommodations, certain matters to limit the economic exposure, including potential legal fees, and
reputational risk created by a disagreement between a carrier and the insured, as well as other E&O matters.
The Company utilizes insurance to provide protection from E&O liabilities that may arise during the ordinary course of
business. Ryan Specialty’s E&O insurance provides aggregate coverage for E&O losses up to $150.0 million in excess of a
per claim retention amount of$5.0 million. The Company’s aggregate coverage for E&O losses increased from$100.0
million to$150.0 million as of June 1, 2024. The Company’s per claim retention amount increased from$2.5 million to
$5.0 million as of June 1, 2023. The Company periodically determines a range of possible outcomes using the best
available information that relies, in part, on projecting historical claim data into the future. Loss contingencies of$4.9
million and$6.4 million were recorded for outstanding matters as of December 31, 2024 and 2023, respectively. Loss
contingencies exclude the impact of any loss recoveries. The Company recognized the net impact of the loss contingencies
and any loss recoveries of$1.8 million,$6.9 million, and$7.5 million of E&O expense for the years ended December 31,
2024,2023, and 2022, respectively, in General and administrative expense on the Consolidated Statements of Income. The
historical claim and commercial accommodation data used to project the current estimates may not be indicative of future
claim activity. Thus, the estimates could change in the future as more information becomes known, which could materially
impact the amounts reported and disclosed herein.
During 2022, the Company placed certain insurance policies through a trading partner with the understanding that the
policies were underwritten by highly rated insurance capital. The policies were instead underwritten by an insurance carrier
that was not considered satisfactory by the Company or the insureds. The Company committed to securing replacement
coverage, to the extent commercially available, from highly rated insurance companies on terms substantially similar to the
insurance coverage originally agreed upon. As a result of this unusual circumstance, the Company has and may continue to
incur losses (“Replacement Costs”) arising from the original placements. The Company has determined that it is probable
that it will be exposed to the Replacement Costs on policies placed with this trading partner. The Company recognized an
estimated loss contingency of$0.3 million and$0.2 million as of December 31, 2024 and 2023, respectively, within
Accounts payable and accrued liabilities on the Consolidated Balance Sheets. Relatedly, the Company has obtained
sufficient evidence from its E&O insurance carriers to conclude that a recovery of the claim for the Replacement Costs, in
excess of the$2.5 million retention, is probable. A loss recovery of$20.2 million and$20.6 million was recorded as of
December 31, 2024 and 2023, respectively, in Other current assets on the Consolidated Balance Sheets. In the aggregate,
the loss contingency and related loss recovery resulted in a$2.5 million expense recognized in the year ended December
31, 2022, and no further expense related to this matter has been recognized since.
It is at least reasonably possible that the estimate of Replacement Costs will change in the near term as policies are
adjusted. Further, exposure to additional losses may arise from policies that had expired prior to, or shortly after, the
discovery of this unusual circumstance, adjustable premiums arising from the addition or deletion of properties over the
policy term, unpaid covered claims, or other damages for losses incurred by our customers. An estimate of these potential
losses cannot be made at this time but could change in the future as more information becomes known.
- RELATED PARTIES
Ryan Investment Holdings
Ryan Investment Holdings, LLC (“RIH”) was formed as an investment holding company designed to aggregate the funds
of Ryan Specialty and Geneva Ryan Holdings, LLC (“GRH”) for investment in Geneva Re Partners, LLC (“GRP”). GRH
was formed as an investment holding company designed to aggregate investment funds of Patrick G. Ryan and other
affiliated investors. Two affiliated investors are LLC Unitholders and directors of the Company, and another is an LLC
Unitholder and employee of the Company. Ryan Specialty does not consolidate GRH as the Company does not have a
direct investment in or variable interest in this entity.
The Company holds a 47% interest in RIH and GRH holds a 53% interest in RIH. RIH has a 50% non-controlling interest
in GRP, and the other 50% is owned by Nationwide Mutual Insurance Company. GRP wholly owns Geneva Re, Ltd.
(“Geneva Re”), a Bermuda-regulated reinsurance company, and GR Bermuda SAC Ltd. (the “Segregated Account
Company”). The Segregated Account Company hasone segre gated account, which is beneficially owned by a third-party
insurance company (the “Third-party Insurer”). RIH is considered a related party variable interest entity under common
control with the Company. The Company is not most closely associated with the variable interest entity and therefore does
not consolidate RIH. The assets of RIH are restricted to settling obligations of RIH, pursuant to Delaware limited liability
company statutes.
The Company is not required to contribute any additional capital to RIH, and its maximum exposure to loss on the equity
method investment is the total invested capital of$47.0 million. The Company may be exposed to losses arising from the
equity method investment as a result of underwriting losses recognized at Geneva Re or losses on Geneva Re’s investment
portfolio. RIH has committed to contribute additional capital to GRP over the next several years. Patrick G. Ryan, through
a trust of which he is the beneficiary and co-trustee, has committed to personally fund any such additional capital
contributions. Any such additional capital contributions under this commitment will not affect the relative ownership of
RIH’s common equity.
The following table summarizes the change in the balance of the Company’s equity method investment in Geneva Re:
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Balance at beginning of period | $46,099 | $38,514 |
| Income from equity method investment in related party | 18,231 | 8,731 |
| Change in share of equity method investment in related party other comprehensive income (loss) | 6,547 | (1,146) |
| Balance at end of period | $70,877 | $46,099 |
Geneva Re
The Company has a service agreement with Geneva Re to provide both administrative services to, as well as disburse
payments for costs directly incurred by, Geneva Re. These direct costs include compensation expenses incurred by
employees of Geneva Re. The Company had$0.3 million and$0.2 million due from Geneva Re under this agreement as of
December 31, 2024 and 2023, respectively.
Ryan Re Services Agreements with Geneva Re
Ryan Re, a wholly owned subsidiary of the Company, is party to a services agreement with Geneva Re to provide, among
other services, certain underwriting and administrative services to Geneva Re. Ryan Re receives a service fee equal to
115% of the administrative costs incurred by Ryan Re in providing these services to Geneva Re. Revenue earned from
Geneva Re was$1.5 million,$1.5 million, and$1.6 million for the years ended December 31, 2024,2023, and 2022,
respectively. Receivables due from Geneva Re under this agreement were$0.7 million as of December 31, 2024 and 2023.
On April 2, 2023, Ryan Re entered into a services agreement with Geneva Re in accordance with which Ryan Re
subcontracted certain services to Geneva Re that Ryan Re is required to provide to the segregated account of the
Segregated Account Company on behalf of the Third-party Insurer. The Company incurred expense of$10.5 million and
$7.5 million during the years ended December 31, 2024 and 2023, respectively. The Company had prepaid expenses of
$5.2 million and$5.3 million as of December 31, 2024 and 2023, respectively, related to this services agreement. The
prepaid expenses are included in Other currents assets on the Consolidated Balance Sheets.
Company Leasing of Corporate Jets
In the ordinary course of its business, the Company charters executive jets for business purposes from Executive Jet
Management (“EJM”), a third-party service provider. Mr. Ryan indirectly owns aircraft that he leases to EJM for EJM’s
charter operations for which he receives remuneration from EJM. The Company pays market rates for chartering aircraft
through EJM, unless the particular aircraft chartered is Mr. Ryan’s, in which case the Company receives a discount below
market rates. Historically, the Company has been able to charter Mr. Ryan’s aircraft and make use of this discount. The
Company recognized expense related to business usage of the aircraft of$1.2 million,$1.0 million, and$1.3 million for the
years ended December 31, 2024,2023, and 2022, respectively.
Personal Guarantee
In April 2021, Mr. Ryan personally guaranteed up to$10.0 million of the financial obligations of the Company under an
agency agreement with certain insurance companies that are affiliated with National Indemnity Company. The Company
did not pay Mr. Ryan any consideration for this guarantee. Mr. Ryan’s guarantee may be replaced by the Company with a
letter of credit at any time, subject to the prior approval of the insurance companies. Mr. Ryan will not personally guarantee
any further additional financial obligations of the Company or any of its subsidiaries.
- INCOME TAXES
The Company is taxed as a corporation for income tax purposes and is subject to federal, state, and local taxes with respect
to its allocable share of any net taxable income from the LLC. The LLC is a limited liability company taxed as a
partnership for income tax purposes, and its taxable income or loss is passed through to its members, including the
Company. The LLC is subject to income taxes on its taxable income in certain foreign countries, in certain state and local
jurisdictions that impose income taxes on partnerships, and on the taxable income of its U.S. corporate subsidiaries.
The components of income before income taxes are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| United States | $270,345 | $224,813 | $159,778 |
| Foreign | 2,209 | 13,112 | 19,414 |
| Income before income taxes | $272,554 | $237,925 | $179,192 |
The components of income tax expense are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Current income tax expense | |||
| Federal | $3,494 | $9,179 | $408 |
| State | 3,704 | 3,338 | 1,840 |
| Foreign | 9,126 | 5,438 | 4,701 |
| Current income tax expense | $16,324 | $17,955 | $6,949 |
| Deferred income tax expense (benefit) | |||
| Federal | 20,497 | 31,941 | 13,164 |
| State | 7,429 | (5,454) | (4,198) |
| Foreign | (1,609) | (997) | 20 |
| Deferred income tax expense | $26,317 | $25,490 | $8,986 |
| Income tax expense | $42,641 | $43,445 | $15,935 |
Reconciliations of income tax expense computed at the U.S. federal statutory income tax rate to the recognized income tax
expense and the U.S. statutory income tax rate to our effective tax rates are as follows:
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2024 · 2023 · 2022 | ||||||
| Income taxes at U.S. federal statutory rate | $57,236 | 21.0% | $49,964 | 21.0% | $37,630 | 21.0% |
| Income attributable to non-controlling interests and nontaxable income | (29,998) | (11.0) | (26,195) | (11.0) | (18,662) | (10.4) |
| Nondeductible expenses | 3,215 | 1.2 | 2,943 | 1.2 | 2,474 | 1.4 |
| State and local taxes, net of federal benefit | 7,804 | 2.9 | 6,642 | 2.8 | 4,671 | 2.6 |
| Equity-based compensation | (13,876) | (5.1) | (2,481) | (1.0) | (2,374) | (1.3) |
| Common Control Reorganizations | 9,519 | 3.5 | 18,356 | 7.7 | — | — |
| Foreign rate differential | 190 | 0.1 | 259 | 0.1 | 376 | 0.2 |
| Change in state rate | 2,968 | 1.1 | (12,091) | (5.1) | (7,477) | (4.2) |
| Change in valuation allowance | 3,571 | 1.3 | 2,908 | 1.2 | — | — |
| Other TRA related (income) loss | (772) | (0.3) | 2,785 | 1.2 | — | — |
| Other | 2,784 | 1.0 | 355 | 0.1 | (703) | (0.4) |
| Income tax expense | $42,641 | 15.7% | $43,445 | 18.2% | $15,935 | 8.9% |
The effective tax rate for the year ended December 31, 2024, was lower than the 21% statutory rate primarily as a result of
the income attributable to non-controlling interests and equity-based compensation, offset by an increase related to the
change in the deferred income tax rates and$9.5 million of non-cash deferred income tax expense from the Common
Control Reorganizations (“CCRs”), which are described below. The effective tax rate for the year ended December 31,
2023, was lower than the 21% statutory rate primarily as a result of the income attributable to non-controlling interests,
change in the deferred income tax rates, and equity-based compensation, offset by an increase of$18.4 million non-cash
deferred income tax expense related to the CCRs.
Uncertain Tax Positions
The Company does not believe it has any significant uncertain tax positions and therefore hasno unrecognized tax benefits
as of December 31, 2024, that if recognized would affect the annual effective tax rate. The Company’s 2021 through 2023
tax years are considered open for federal examination purposes. The 2020 through 2023 tax years are considered open for
purposes of federal examination under the statutes of limitations for the LLC, which continues to file an annual U.S. Return
of Partnership Income, and the Company’s C-Corporation subsidiaries. As of the issuance date of this Form 10-K, one of
the LLC’s subsidiaries is under U.S. federal and state examination for the 2020 tax year andanother is under U.S. federal
examination for the 2022 tax year. The Company is under examination by a local tax jurisdiction for the 2021 tax year.
There are no other on-going U.S. federal, state, or foreign tax audits or examinations as of the date of issuance of this Form
10-K.
Common Control Reorganizations (CCRs)
Subsequent to the acquisition of Innovisk, which was purchased by Ryan Specialty Holdings, Inc., the Company
reorganized Innovisk and transferred the resulting LLCs and foreign subsidiaries to Ryan Specialty, LLC. This legal entity
reorganization was considered a transaction between entities under common control. The CCR resulted in deferred tax
liabilities of$40.7 million and a non-cash deferred income tax expense of$11.4 million. Additionally, the difference
between the carrying value and the fair value of the investments transferred under common control resulted in an increase
of$7.3 million to Non-controlling interests on the Consolidated Statements of Stockholders’ Equity during the year ended
December 31, 2024.
Subsequent to the acquisitions of Socius and AccuRisk, which were purchased by a wholly owned subsidiary of Ryan
Specialty Holdings, Inc., the Company converted Socius to an LLC and reorganized AccuRisk and transferred those LLCs
to Ryan Specialty, LLC. These legal entity reorganizations were considered transactions between entities under common
control. The CCRs resulted in a net, non-cash deferred income tax expense of$18.4 million. Additionally, the difference
between the carrying value and the fair value of the investments transferred under common control resulted in an increase
of$18.9 million to Non-controlling interests on the Consolidated Statements of Stockholders’ Equity during the year ended
December 31, 2023. During the year ended December 31, 2024, as a result of the measurement period adjustments for
AccuRisk, the Company recognized$1.9 million of non-cash deferred income tax benefit.
Deferred Tax Assets and Liabilities
The components of deferred tax assets and liabilities are as follows:
| As of December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Deferred tax assets | ||
| Net operating losses | $14,687 | $1,681 |
| Investment in the LLC | 429,850 | 375,218 |
| Start-up costs | 6,246 | 6,820 |
| Equity-based compensation | 1,628 | 686 |
| Tax credits | 5,491 | 2,908 |
| Capitalized research and development | 890 | — |
| Other accrued items | 151 | — |
| Total deferred tax assets | $458,943 | $387,313 |
| Valuation allowances | (7,759) | (3,272) |
| Deferred tax assets, net of valuation allowance | $451,184 | $384,041 |
| Deferred tax liabilities | ||
| Intangibles | (42,817) | (53) |
| Fixed assets | — | (149) |
| Other accrued items | — | (78) |
| Deferred tax liabilities | $(42,817) | $(280) |
| Net Deferred tax assets | $408,367 | $383,761 |
During the years ended December 31, 2024 and 2023, the changes in Deferred tax assets were primarily the result of
reductions to the deferred tax assets from the CCRs of$41.2 million and $77.0 million, respectively, offset by increases in
the investment in the LLC’s deferred tax assets of$97.1 million and$63.9 million, respectively, due to exchanges of LLC
Common Units for Class A common stock. Additionally, during the year ended December 31, 2024, Deferred tax assets
increased by$13.9 million due to equity-based compensation. The change in the Deferred tax liabilities during the year
ended December 31, 2024, was primarily the result Deferred tax liabilities established on acquired intangibles in
connection with the acquisitions of Castel and Innovisk of$21.8 million and$21.0 million, respectively.
As of December 31, 2024, the Company had$40.2 million of federal net operating loss (“NOL”) carryforwards with an
indefinite carryforward period,$37.2 million of state NOL carryforwards that will begin toexpire in 2036, and$14.1
million of foreign NOL carryforwards with an indefinite carryforward period. The Company has recorded valuation
allowances of$4.4 million and$9.0 million against the state and foreign NOLs, respectively.
As of December 31, 2024, the Company had$5.5 million in foreign tax credit carryforwards that will begin to expire in
- The Company assessed the available positive and negative evidence, including tax planning strategies and recent
results of foreign operations, to determine whether it was more likely than not that the existing deferred tax asset would be
realized. A significant piece of objective negative evidence evaluated was the inability to use all available foreign tax
credits for the year ended December 31, 2024. On the basis of this evaluation, a full valuation allowance of$5.5 million
was recorded with respect to this deferred tax asset as of December 31, 2024. The amount of the deferred tax asset
considered realizable, however, could be adjusted in the future if estimates of the Company’s ability to use the available
foreign tax credits change.
As of December 31, 2024, the Company concluded that, based on the weight of all available positive and negative
evidence, the deferred tax assets with respect to the Company’s basis difference in its investment in the LLC, start-up costs,
and U.S. net operating losses are more likely than not to be realized. As such, no valuation allowance has been recognized
against those deferred tax assets. The Company has recorded a full valuation allowance against its foreign tax credits and
valuation allowances against certain state and foreign NOLs. The valuation allowances will be maintained until there is
sufficient evidence to support the reversal of all or some portion of the allowances.
Tax Receivable Agreement (TRA)
The Company recognizes a liability on the Consolidated Balance Sheets based on the undiscounted estimated future
payments under the TRA. The amounts payable under the TRA will vary depending upon a number of factors, including
the amount, character, and timing of the taxable income of the Company in the future. Based on current projections, the
Company anticipates having sufficient taxable income to be able to realize the benefits and has recorded Tax Receivable
Agreement liabilities of$436.3 million related to these benefits on the Consolidated Balance Sheets as of December 31,
- The following summarizes activity related to the Tax Receivable Agreement liabilities:
| Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | |
|---|---|---|---|---|
| Balance at December 31, 2022 | $150,311 | $85,016 | $60,020 | $295,347 |
| Exchange of LLC Common Units | 47,409 | 6,489 | 14,689 | 68,587 |
| Remeasurement – change in state rate | 5,910 | 905 | 3,549 | 10,364 |
| Interest expense | — | — | 806 | 806 |
| Payments | (8,962) | (6,596) | (648) | (16,206) |
| Balance at December 31, 2023 | $194,668 | $85,814 | $78,416 | $358,898 |
| Exchange of LLC Common Units | 73,433 | 5,660 | 21,982 | 101,075 |
| Remeasurement – change in state rate | (932) | (391) | (1,183) | (2,506) |
| Remeasurement – foreign tax credits | (895) | — | — | (895) |
| Interest expense | — | — | 1,302 | 1,302 |
| Payments | (13,041) | (7,668) | (869) | (21,578) |
| Balance at December 31, 2024 | $253,233 | $83,415 | $99,648 | $436,296 |
The increases in the TRA liabilities due to exchanges of LLC Common Units for Class A common stock were recognized
in Additional paid-in capital on the Consolidated Statements of Stockholders’ Equity. During the year ended December 31,
2024, the Company remeasured the TRA liabilities due to changes in state tax rates, which decreased its estimated cash tax
savings rate from 26.12% to 26.00%. During the year ended December 31, 2023, the Company remeasured the TRA
liabilities due to changes in state tax rates, which increased its estimated cash tax savings from 25.53% to 26.12%. The
changes were recognized in Other non-operating loss on the Consolidated Statements of Income. Total realized tax savings
in 2024 for the year ended December 31, 2023, from each of the tax attributes associated with the TRA were$24.4 million;
$20.7 million, exclusive of the related accrued interest, was paid to current and certain former LLC unitholders,
representing 85% of the realized tax savings. The remaining 15%, or$3.7 million, of the realized tax savings was retained
by the Company.
Non-controlling Interest Holders’ Tax Distributions
The Company declared tax distributions to the non-controlling interest holders of$84.8 million,$74.6 million, and$28.7
million during the years ended December 31, 2024,2023, and 2022, respectively. Non-controlling interest holders’ tax
distributions for quarterly estimates are generally paid throughout the year they relate to, and a final payment is made in the
first half of the subsequent year.
Other Comprehensive Income (Loss)
The following table summarizes the tax effects on the components of Other comprehensive income (loss):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Gain on interest rate cap | $(1,945) | $(1,628) | $(2,727) |
| Gain on interest rate cap reclassified to earnings | 3,101 | 2,734 | — |
| Foreign currency translation adjustments | 1,370 | (272) | 538 |
| Change in share of equity method investment in related party | (842) | 173 | 713 |
- ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Changes in the balance of Accumulated other comprehensive income (loss), net of tax, are as follows:
| Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss) 1 | Total | |
|---|---|---|---|---|
| Balance at December 31, 2021 | $— | $1,827 | $(113) | $1,714 |
| Other comprehensive income (loss) before reclassifications | 24,389 | (4,684) | (5,774) | 13,931 |
| Amounts reclassified to earnings | (2,175) | — | — | (2,175) |
| Other comprehensive income (loss) | $22,214 | $(4,684) | $(5,774) | $11,756 |
| Less: Non-controlling interests | 14,149 | (3,014) | (3,700) | 7,435 |
| Balance at December 31, 2022 | $8,065 | $157 | $(2,187) | $6,035 |
| Other comprehensive income (loss) before reclassifications | 12,028 | 2,125 | (973) | 13,180 |
| Amounts reclassified to earnings | (20,161) | — | — | (20,161) |
| Other comprehensive income (loss) | $(8,133) | $2,125 | $(973) | $(6,981) |
| Less: Non-controlling interests | (4,765) | 1,300 | (557) | (4,022) |
| Balance at December 31, 2023 | $4,697 | $982 | $(2,603) | $3,076 |
| Other comprehensive income (loss) before reclassifications | 14,003 | (8,914) | 5,708 | 10,797 |
| Amounts reclassified to earnings | (21,623) | — | — | (21,623) |
| Other comprehensive income (loss) | $(7,620) | $(8,914) | $5,708 | $(10,826) |
| Less: Non-controlling interests | (4,358) | (4,922) | 3,326 | (5,954) |
| Balance at December 31, 2024 | $1,435 | $(3,010) | $(221) | $(1,796) |
1 Change in share of equity method investment in related party other comprehensive income (loss) on the Consolidated
Statements of Comprehensive Income.
- SEGMENT REPORTING
Segment Information
Ryan Specialty is organized as a single operating and reporting segment. The Company’s chief operating decision maker
(“CODM”) is its Chief Executive Officer. The Company has identified its single operating segment utilizing a management
approach that aligns with the manner in which the CODM utilizes the Company’s consolidated financial information for
resource allocation and performance evaluation. Refer to Note 1, Basis of Presentation, for a description of the Company’s
products and services and to Note 3, Revenue from Contracts with Customers, for the disaggregation of revenue by
Specialty.
The CODM utilizes consolidated net income as the primary metric to monitor budget versus actual results, assess the
performance of the business, and make decisions regarding resource allocation. The following table provides information
about the Company’s revenue and includes a reconciliation to net income:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net commissions and fees | $2,455,671 | $2,026,596 | $1,711,861 |
| Fiduciary investment income | 60,039 | 50,953 | 13,332 |
| Total revenue | $2,515,710 | $2,077,549 | $1,725,193 |
| Compensation-related expense1 | 1,426,674 | 1,222,342 | 1,021,823 |
| General and administrative expense2 | 277,813 | 230,467 | 185,956 |
| Other segment items3 | 238,640 | 144,401 | 118,173 |
| Depreciation and amortization | 167,630 | 115,837 | 109,291 |
| Change in contingent consideration | (22,859) | 5,421 | 442 |
| Interest income | (21,509) | (31,986) | (10,579) |
| Interest expense | 179,957 | 151,493 | 115,408 |
| Loss (income) from equity method investment in related party | (18,231) | (8,731) | 414 |
| Income tax expense | 42,641 | 43,445 | 15,935 |
| Other non-operating loss | 15,041 | 10,380 | 5,073 |
| Net income | $229,913 | $194,480 | $163,257 |
1 Compensation-related expense includes salaries, commissions, bonus compensation, benefits, payroll taxes, and
contractor costs, and excludes equity-based compensation expense, acquisition, and restructuring related expenses.
2 General and administrative expense includes travel and entertainment, professional services, occupancy, IT related costs,
and other operating costs, and excludes acquisition and restructuring related expenses.
3 Other segment items include equity-based compensation expense, and acquisition and restructuring related compensation
and general and administrative expenses.
Geographic Information
Revenue is primarily recognized based on the country in which the services are performed. The below table illustrates the
geographic regions for the Company’s revenue:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| United States | $2,391,980 | $2,022,579 | $1,676,042 |
| Foreign | 123,730 | 54,970 | 49,151 |
| Total revenue | $2,515,710 | $2,077,549 | $1,725,193 |
The Company did not have material revenue from operations in any individual foreign country for the years ended
December 31, 2024,2023, and 2022. Asset information is not presented to the CODM. Substantially all of the Company’s
tangible long-lived assets are located in the United States; therefore, geographic information for long-lived assets is not
presented.
- SUPPLEMENTAL FINANCIAL INFORMATION
Interest Income
The Company earned interest income of$21.5 million,$32.0 million, and$10.6 million during the years ended
December 31, 2024, 2023, and 2022, respectively, on its operating Cash and cash equivalents. Interest income is
recognized in Interest expense, net on the Consolidated Statements of Income.
Supplemental Cash Flow Information
The following represents the supplemental cash flow information of the Company:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cash paid for: | |||
| Interest, net1 | $136,953 | $128,380 | $88,504 |
| Income taxes, net of refunds | 27,331 | 16,401 | 11,226 |
| Non-cash investing and financing activities: | |||
| Non-controlling interest holders’ tax distributions declared but unpaid | $2,109 | $35 | $— |
| Tax Receivable Agreement liabilities | 101,075 | 68,587 | 26,003 |
| Dividend Equivalents and Declared Distributions liabilities | 4,246 | — | — |
| Contingently returnable consideration | 4,868 | — | — |
| Contingent consideration liabilities | 103,769 | 11,238 | — |
1 Interest paid is presented net of$24.7 million,$22.9 million, and$2.2 million of cash received in connection with the
Company’s interest rate cap for the years ended December 31, 2024,2023, and 2022, respectively. See Note 13,
Derivatives, for further information on the interest rate cap.
- SUBSEQUENT EVENTS
The Company has evaluated subsequent events through February 21, 2025, and has concluded that no events have occurred
that require disclosure other than the events listed below.
On February 3, 2025, the Company completed the acquisition of Velocity Risk Underwriters, LLC, an MGU specializing
in first-party insurance coverage for catastrophe exposed properties headquartered in Nashville, Tennessee, for
approximately$525.0 million cash consideration, subject to customary purchase price adjustments. This acquisition will
include contingent consideration in its final purchase price, however, the Company has not yet completed the valuation of
the contingent consideration or the purchase price allocation to the acquired assets and assumed liabilities as of the date of
this filing.
On February 20, 2025, the Company’s Board of Directors declared a regular quarterly cash dividend of $0.12 per share of
outstanding Class A common stock. The regular quarterly dividend will be paid on March 18, 2025, to shareholders of
record of Class A common stock as of the close of business on March 4, 2025. Any future dividends will be subject to the
approval of the Company’s Board of Directors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.